Page last updated: 2024-08-22

antimony and Leishmaniasis, Visceral

antimony has been researched along with Leishmaniasis, Visceral in 272 studies

Research

Studies (272)

Timeframe	Studies, this research(%)	All Research%
pre-1990	112 (41.18)	18.7374
1990's	71 (26.10)	18.2507
2000's	40 (14.71)	29.6817
2010's	42 (15.44)	24.3611
2020's	7 (2.57)	2.80

Authors

Authors	Studies
Kumar, A; Kumar, V; Kumari, S; Pandey, K; Ravidas, V; Tiwari, RK	1
Das, AK; Das, S; Datta, S; Khanra, S; Manna, M; Roy, S; Sarraf, NR	1
Leprohon, P; Ouellette, M; Potvin, JE; Queffeulou, M; Sundar, S	1
Bhattacharyya, SN; Mukherjee, B; Mukherjee, K; Mukhopadhayay, R; Nanda, P; Ravichandiran, V; Roy, S	1
Bhattacharyya, M; Bodhale, NP; Pai, K; Saha, B; Sundar, S	1
Chen, J; Li, J; Ma, G; Satoskar, AR; Zheng, Z	1
Alves, F; Brack, M; Dahal, P; Guerin, PJ; Halleux, CM; Hawryszkiewycz, A; Maguire, BJ; Ngu, R; Olliaro, PL; Rashan, S; Singh-Phulgenda, S; Stepniewska, K	1
Bhandari, V; Deep, DK; Dujardin, JC; Salotra, P; Singh, R; Sundar, S; Verma, A	1
Dey, R; Dube, A; Gannavaram, S; Kariyawasam, KKGDUL; Karunanayake, P; Karunaweera, ND; Nakhasi, HL; Selvapandiyan, A; Senanayake, SASC; Siriwardana, HVYD	1
Almeida, RP; Bomfim, LG; Borges, VM; Corrêa, CB; Cruz, GS; Jesus, AR; Lipscomb, MW; Magalhães, LS; Mota, SG; Moura, TR; Tanajura, DM	1
Ait-Oudhia, K; Benikhlef, R; Eddaikra, N; Harrat, Z; Kherrachi, I; Moulti-Mati, F; Oury, B; Sereno, D	1
Clos, J; Cuypers, B; D'Haenens, E; De Muylder, G; Domagalska, MA; Dujardin, JC; Dumetz, F; Imamura, H; Maes, I; Zander, D	1
Das, S; Dujardin, JC; Ghosh, J; Guha, R; Mandala, A; Naskar, K; Roy, S; Sundar, S	1
Cota, GF; de Sousa, MR; Fereguetti, TO; Rabello, A	1
Dujardin, JC; Kyle, DE; Manetsch, R; Pandharkar, T; Rijal, S; Van Horn, KS; Vanaerschot, M; Vesely, B; Wang, MZ; Werbovetz, KA; Yang, S; Zhu, X	1
Batista, MA; Castro, RA; Ferreira, FM; Frézard, F; Licio, CS; Moura, SL; Rezende, SA; Silva-Barcellos, NM; Silveira-Lemos, D; Souza, JB; Souza-Testasicca, MC	1
Dujardin, JC; Mukherjee, B; Mukherjee, S; Mukhopadhyay, R; Naskar, K; Roy, S; Sundar, S	1
Chatterjee, M; Singh, N; Sundar, S	1
Coelho, AC; Cotrim, PC; Oliveira, JC; Reimão, JQ; Trinconi, CT; Uliana, SR	1
Bhattacharjee, H; Charret, KS; Mandal, G; Mandal, S; Mukhopadhyay, R; Papadopoulou, B; Sharma, M	1
Garg, M; Goyal, N	1
Das, RP; Mathur, R; Ranjan, A; Shaha, C	1
Barbas, C; Canuto, GA; Castilho-Martins, EA; López-Gonzálvez, Á; Rivas, L; Rojo, D; Tavares, MF	1
Das, S; Dujardin, JC; Mukherjee, B; Mukherjee, S; Mukhopadhyay, R; Naskar, K; Paul, J; Roy, S; Saha, B; Sundar, S	1
Aragão, MT; Braz, JM; da Silva, ÂM; de Almeida, RP; de Jesus, AR; de Moura, TR; de Oliveira, FA; Santos, LF; Santos, ML; Santos, PL	1
Blackburn, G; Carter, KC; Coombs, GH; Cotton, JA; Downing, T; Dujardin, JC; Freeman, TM; Illingworth, CJ; Imamura, H; Khanal, B; Lonchamp, J; Rijal, S; Sanders, M; Shaw, CD	1
Belhouari, K; Buffet, P; Calin, R; Caumes, E; Chabert, P; Charlier, C; Faye, A; Gilquin, J; Jouffroy, R; Lanternier, F; Legendre, C; Lortholary, O; Mamzer, MF; Miailhes, P; Morizot, G; Mouri, O; Peyramond, D; Siriez, JY; Tubiana, R; Yera, H	1
Berg, M; Berriman, M; Bhattarai, NR; Boelaert, M; Cotton, JA; Cuypers, B; De Koning, HP; De Muylder, G; Decuypere, S; Domagalska, M; Downing, T; Dujardin, JC; Dumetz, F; Imamura, H; Khanal, B; Maes, I; Maes, L; Mannaert, A; Ostyn, B; Prajapati, VK; Rai, K; Rijal, S; Roy, S; Sanders, MJ; Schönian, G; Settimo, L; Sharma, S; Stark, O; Sundar, S; Uranw, S; Van den Broeck, F; Vanaerschot, M; Vanhollebeke, B	1
Kureel, AK; Rai, AK; Saini, S; Tiwari, P; Verma, P	1
Castanys, S; Corpas-López, V; Gamarro, F; García-Hernandez, R; Gómez Pérez, V; Martín-Sanchez, J; Tomás, AM	1
Das, AK; Das, S; Khanra, S; Manna, M; Roy, S; Sarraf, NR	1
Croft, SL	1
Chatterjee, M; Mandal, G; Saha, P; Sarkar, A; Singh, N; Sundar, S	1
Brustoloni, YM; Cônsolo, CE; Melnikov, P; Zanoni, LZ	1
Madhubala, R; Sharma, A	1
Chatterjee, M; Madhubala, R; Maharjan, M; Mandal, S; Singh, S	1
GONNET, L	1
CHAKRAVARTY, NK; SEN GUPTA, PC	2
Chatterjee, M; Fairlamb, AH; Mandal, G; Singh, N; Sundar, S; Wyllie, S	2
DASTIDAR, SK	1
BOSE, AN; GHOSH, TN	1
Cañavate, C; Cos, P; Cruz, I; Dorval, ME; Dujardin, JC; Inocêncio da Luz, R; Maes, L; Romero, GA; Van Assche, T	1
Boelaert, M; Fairlamb, AH; Feldmann, J; Perry, MR; Prajapati, VK; Sundar, S; Wyllie, S	1
Duncan, R; Garg, M; Goyal, N; Nakhasi, HL; Sundar, S	1
Berriman, M; de Doncker, S; Decuypere, S; Downing, T; Dujardin, JC; Imamura, H; Maes, I; Rijal, S; Sanders, M; Schönian, G; Stark, O; Sundar, S; Vanaerschot, M	1
Korkmaz, M; Özbel, Y; Şakru, N; Töz, SÖ	1
Bhaumik, SK; De, T; Karmakar, S; Naskar, K; Paul, J	1
Bhandari, V; Kulshrestha, A; Kumar, D; Negi, NS; Salotra, P; Singh, R	1
Chatterjee, M; Ghosh, S; Pakrashi, S; Roy, D; Sarkar, A; Sen, S	1
Brunker, K; Coombs, GH; Decuypere, S; Dujardin, JC; Imamura, H; Khanal, B; Müller, S; Rijal, S; Vanaerschot, M	1
Bhandari, V; Carter, K; Cos, P; Dujardin, JC; Hendrickx, S; Inocêncio da Luz, RA; Kuypers, K; Lonchamp, J; Maes, L; Rijal, S; Salotra, P; Shaw, CD; Sundar, S	1
Bhandari, V; Gurumurthy, S; Kuhls, K; Salotra, P; Schnonian, G; Subba Raju, BV	1
Gangwar, S; Goyal, N	1
Berg, M; Decuypere, S; Dujardin, JC; Roy, S; Vanaerschot, M	1
Jarvis, JN; Lockwood, DN	1
Duerr, HP; Dujardin, JC; Eichner, M; Stauch, A; Sundar, S; Vanaerschot, M	1
Das, AK; Dujardin, JC; Mukherjee, B; Mukherjee, S; Mukhopadhyay, R; Naskar, K; Roy, S; Sundar, S	1
Buffels, R; Jha, TK; Mishra, M; Singh, VR; Sundar, S; Thakur, CP	1
Coffman, RL; Freeman, S; Kaplan, G; Lu, CM; Mauze, S; Moreira, AL; Murray, HW	1
Christides, C; Disdier, P; Granel, B; Horshowski, N; Minodier, P; Richard-Vitton, T; Serratrice, J; Thomassin, JM; Weiller, PJ	1
Barbosa, MC; Bordin, JO; Castelo, A; Chiba, AK; Vilela, RB	1
Bandyopadhyay, S; Ghosh, M; Maitra, S; Mandal, L; Pal, C; Ray, M	1
BOIX BARRIOS, J	1
BHATTACHARYYA, B; DAS, AK; SANYAL, NN; SEN GUPTA, PC	1
BERNARD, R; GIRAUD, P; VINCENT, P	1
BRAHMACHARI, PN; KAR, CC; MAITI, CR	1
MATOS, J; VELASCO, JA	1
DI CARLO, FC; PESSAT, OA; WILDE, H	2
BOUDIN, G; PEPIN, B	1
CARVALHO, O	1
PI FERRER, A; SALA GINABREDA, JM; WOESSNER CASAS, S	1
BENABADJI, A; CHARLAS, R	1
LARRIBAUD, J; MEMIN, Y; PERNOD, J	1
CAHILL, KM	2
KANIN, HJ; WELSH, EC	1
DEGREGORIO, G; QUATTROCCHI, G	1
GIRAUD, F; ORSINI, A; RAYBAUD, C	1
SCHNEIDER, J	1
CACHIA, EA; FENECH, FF	1
TELLA, A	1
DEMPSEY, JJ	1
CAMBI, P	1
MIRZOIAN, NA	1
Laguna, F	1
BOIX BARRIOS, J; SANCHO PASQUAU, V	1
TUCKMAN, E	1
de YTURRIAGA, E; GONZALEZ BOTELLA, S	1
Duarte, G; El-Beitune, P; Figueiró-Filho, EA; Maia, TL; Quintana, SM	1
Murray, HW	3
Narayan, S; Ranjan, A; Thakur, CP	1
Delis, D; Kafetzis, DA; Liapi, G; Mavrikou, M; Stabouli, S; Velissariou, IM	1
Marty, P; Rosenthal, E	1
Basu, JM; Basu, R; Bhaumik, S; De, T; Naskar, K; Roy, S	1
Gerstl, S; Guerin, PJ; Haaskjold, AA; Olliaro, PL; Rottingen, JA; Sundar, S	1
Cascio, G; Titone, L	1
Ficker, E; Kuryshev, YA; Wan, X; Wang, L; Wible, BA	1
Ahmed, AE; Hussein, MH; Khalil, EA; Musa, AM	1
Pandey, HP; Singh, RK; Sundar, S	1
Carnevalini, M; Ceccarelli, G; d'Ettorre, G; Forcina, G; Massetti, AP; Mastroianni, CM; Vullo, V; Zaffiri, L	1
Kothari, H; Kumar, P; Singh, N; Sundar, S	1
Boelaert, M; Diap, G; Gerstl, S; Guerin, PJ; Meheus, F; Van der Stuyft, P; Vanlerberghe, V	1
Goyal, N; Gupta, S; Mittal, MK; Rai, S; Sundar, S	1
Blanc, P; Garnier, JM; Minodier, P; Noël, G; Retornaz, K; Uters, M	1
Ammari, L; Belhadj, S; Ben Chaabene, T; Chaker, E; Kanoun, F; Kilani, B; Tiouiri, H; Toumi, A	1
Steck, EA	1
García de Miguel, MJ; García Hortelano, J; López-Herce Cid, J; Ramirez Balza, O; Vidal López, ML	1
Caravagno, C; Maturana, G; Miranda, C; Moyano, C; Osorio, G; Retamales, I; Ubilla, M	1
Alving, CR; Chapman, WL; Hanson, WL; Hendricks, LD; Swartz, GM; Waits, VB	1
Berman, JD; Hanson, WL; Keenan, CM; Lamb, SR; Waits, VB	1
Alving, CR; Hanson, WL; Munnell, JF; Weldon, JS	1
Duvivier, A; Lefèbvre, P; Nemery, A	1
Kokkini, G; Liosis, G; Papaefstathiou, J; Vrionis, G	1
Alving, CR; Chapman, WL; Hanson, WL; Hendricks, LD	1
Chapman, WL; Davidson, DE; Hanson, WL; Hendricks, LD; Hockmeyer, WT; Waits, VB	1
Bódalo Herrero, A; Cambronero Galache, M; Casado Flores, J; Casquero Junquera, J; Courel Grijalba, A; Martínez Cortés, F	1
Berman, JD; Chulay, JD; Hendricks, LD; Oster, CN	1
Almagro, M; Cabrera Torres, A; De Pablos Gallego, JM; De Puerta, S; Esquivias, JJ; Gómez Morales, M; López Garrido, P	1
Aram, GN; Arya, LS; Fazal, MI; Goel, RG; Qureshi, MA; Singh, M	1
Altman, G; Ballin, A; Boichis, H; Rotem, Y; Theodor, R	1
Almaviva, M; Esposito, R; Lazzarin, A	1
Carcassonne, Y; Imbert, C; Sainty, D; Sebahoun, G	1
Alving, CR; Chapman, WL; Hanson, WL; Hendricks, LD; Steck, EA; Swartz, GM; Waits, VB	1
Bienzle, U; Reindke, B; Wittermann, C	1
Belal-Kacemi, L; Ben Ismail, R; Dellagi, K; Laouini, D; Louzir, H; Sassi, A	1
Kager, PA; Lustig, V; Meenhorst, PL	1
Boer, C; Davidson, R; de Jong, J; de Wilde, E; Seaman, J; Sondorp, E; Wilkinson, R	1
Singh, S; Sundar, S	1
Baillie, AJ; Carter, KC; Williams, DM	1
Dedet, JP; Lambert, M; Pratlong, F	1
Lesser, ML; Murray, HW; Rosenkaimer, F; Sundar, S	1
Bryceson, A; Desjeux, P; Gradoni, L	1
Alcácer, F; Aznar, J; Colomina, J; Ferriols, F; Magraner, J; Orovitg, F; Rodilla, F	1
Baily, GG; Nandy, A	1
Alonso, MJ; García-Samaniego, J; González-Lahoz, JM; Laguna, F; Redondo, C; Soriano, V; Valencia, E	1
Badaró, F; Badaró, R; Carvalho, JS; Ho, JL; Johnson, WD; Jones, TC; Nascimento, C; Reed, SG; Russo, D	1
Closa, JM; Font, A; Gines, C; Mascort, J	1
Albertini, M; Gari-Toussaint, M; Le Fichoux, Y; Léger, I; Manassero, J; Mariani, R; Marty, P; Tommasi, C	1
Calabrese, S; Laguna del Estal, P; Martín, T; Zabala, JA	1
Desmyttere, S; Hachimi-Idrissi, S; Otten, J	1
Alcindor, LG; Ayrault-Jarrier, M; Bekaert, ED; Dubois, DY; Kallel, R; Mebazza, A	1
Badaro, R; Johnson, WD	1
Bienzle, U; Feldmeier, H; Harms, G; Omena, S; Pedrosa, C; Richter, J; Rosenkaimer, F; Sandkamp, B; Zwingenberger, K	1
Ben Meriem, C; Besbes, A; Ghedira, L; Guediche, MN; Hamza, A; Pousse, H; Radhouane, M	1
de Lalla, F; Franzetti, M; Gradoni, L; Pellizzer, G; Stecca, C; Vespignani, M	1
Barral, A; Barral-Netto, M; Carvalho, EM; Schriefer, A	1
Hariprashad, J; McDermott, DF; Murray, HW; Stoeckle, MY	1
Ozsoylu, S	1
Cortes, E; de Otero, J; Gasser, I; Ocaña, I; Pahissa, A; Ribera, E	1
Alcázar, R; de la Torre, M; Peces, R	1
Alberola, J; Arboix, M; Esteban, M; Valladares, JE	1
Boix, V; Massa, B; Pérez-Mateo, M; Portilla, J; Torrús, D	1
Derouin, F; Farinotti, R; Gangneux, JP; Garin, YJ; Sulahian, A	1
Escorihuela Esteban, R; Leal Orozco, A; Otero Fraguas, M; Pérez Brea, A; Ruiz Moreno, M	1
Hariprashad, J; Murray, HW	1
Buscaylet, S; Durand, JM; Kaplanski, G; Penot-Ragon, C; Soubeyrand, J	1
Hariprashad, J; Murray, HW; Rainey, PM; Roberts, WL	1
Bejaoui, M; Besbes, A; Guediche, MN; Khelif, A; Laradi-Chebil, S; Nadrid, A; Pousse, H; Radhouane, M	1
Deniau, M; Dumon, H; Faraut-Gambarelli, F; Faugère, B; Giusiano, B; Marty, P; Michel, G; Piarroux, R	1
Astier, A; Bories, C; Deniau, M; Durand, R; Fusai, T; Houin, R; Paul, M; Rivollet, D	1
Alcázar, R; Benezet, J; De la Torre, M; Ortega-Carnicer, J	1
Agrawal, NK; Horwith, GS; Murray, HW; Sinha, PR; Sundar, S	1
Makharia, MK; Murray, HW; Sharma, S; Singh, VP; Sundar, S	1
Adrados, M; Alvar, J; González-Lahoz, JM; Jiménez, MI; Laguna, F; Martínez, ML; Martínez, P; Moreno, V; Polo, R; Soriano, V; Valencia, ME; Verdejo, J	1
Amusategui, I; Sainz, A; Tesouro, MA	1
Agrawal, NK; Berman, JD; Murray, HW; Rainey, PM; Singh, VP; Sinha, PR; Srivastava, R; Sundar, S	1
Berenguer, J; Cano, J; Fernández Alvarez, JM; Gimeno, M; Gonzalo Lafuente, JC; Vázquez-Piñeiro, T	1
Dumon, H; Garnier, JM; Minodier, P; Perrimond, H; Piarroux, R; Unal, D	1
Jha, TK; Olliaro, P	1
Ahmad, S; Rahim, F; Rehman, F; Zada, B	1
Goyal, AK; More, DK; Murray, HW; Singh, MK; Sundar, S	1
Bitnun, A; Ephros, M; Shaked, P; Waldman, E; Zilberstein, D	1
Chantraine, JM; Dresse, MF; Gillet, P; Hoyoux, C; Marguglio, A; Thiry, A	1
Belloli, C; Bertini, S; Carli, S; Crescenzo, G; Mengozzi, G; Ormas, P; Zaghini, A	1
Briner, V; Heer, K; Pfister, D	1
Abraham, Y; Akuffo, H; Ali, A; Berhe, N; Britton, S; Desjeux, P; Gebre-Michael, T; Hailu, A; Sönnerborg, A; Wolday, D	1
Herwaldt, BL	1
Alunda, JM; Cuquerella, M; de la Fuente, C; Fernández-Pérez, FJ; Gómez-Muñoz, MT; Méndez, S	1
Corzo, JE; de la Rosa, R; Delgado, J; González-Moreno, MP; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A	1
Delph-Etienne, S; Murray, HW	1
Everlien, H; Hockertz, S	1
González Lahoz, J; Laguna, F; Valencia, ME	1
Goyal, AK; Makharia, MK; Mandal, AK; Murray, HW; Singh, VP; Sundar, S	1
Hantson, P; Haufroid, V; Lambert, M; Luyasu, S	1
Gimeno, L; Llorente, S; Moreno, S; Navarro, MJ; Rodriguez-Gironés, M	1
Montelibano, C; Murray, HW; Peterson, R; Sypek, JP	1
Márquez, M; Rivero, A; Santos, J	1
Murray , HW	1
Cavaleyra, M; Guilvard, E; Holzmuller, P; Lemesre, JL; Maquaire, S; Ouaissi, A; Sereno, D	1
Sundar, S	1
Force, L; Hernández, JA; Navarro, JT	1
Berenguer, J; Cosín, J; López, JC; Miralles, P; Padilla, B	1
Chance, ML; New, RR; Peters, W; Thomas, SC	1
Loewe, H; Raether, W; Seidenath, H	1
Löhr, H; Wolf, H	1
Chapman, WL; Hanson, WL; Kinnamon, KE	1
Gupta, AK; Kumar, SC; Sinha, KP; Thakur, CP	1
de Benoist, B; Gardéa, A; Haarscher, A; Kien, T; Rohmer, A	1
Marsden, PD	1
Asseburg, U; Buchner, T; Roessner, A; Wirth, W	1
Andreeva, NE; Demidova, AE; Margulis, MI; Ul'ianova, VI	1
Mansour, NS; Mikhail, JW	1
Borgatti, MA; La Placa, M; Manson-Bahr, PE; Musumeci, S; Pampiglione, S	1
Marchi, A; Monafo, V; Ugazio, AG	1
Sen Gupta, PC	1
Baillie, AJ; Carter, KC; Collins, M	1
Zijlstra, EE	1
Bouchaud, O; Cabié, A; Coulaud, JP; Deluol, AM; Leprètre, A; Matheron, S	1
Alonso Díaz, C; Alonso Jiménez, C; Carreño Noguera, E; Grau Segura, E; Querol Ribelles, JM; Serrat Pérez, C	1
Bouchouareb, D; Moulin, B; Ollier, J; Olmer, M; Purgus, R	1
Enriquez, A; García Aguado, C; Gazapo, E; González Lahoz, JM; Laguna, F; Martínez, P; Puente, S	1
Aggarwal, P; Gupta, U; Saluja, S; Singh, S; Wali, JP	1
Andreeva, N; Georgiev, A; Kuzmanova, E; Popov, G	1
Dumas, ML; Dumas, R; Morin, D; Valette, H	1
Granger, AM; Mohanty, SK; Murray, HW	1
Almeida, RP; Badaró, F; Badaró, R; Barral, A; Barral-Netto, M; Carvalho, EM; Falcoff, E; Falcoff, R; Pedral-Sampaio, D; Santos, SB	1
Badaro, FS; Badaro, R; Barral, A; Barral-Netto, M; Brandely, M; Carvalho, EM; Carvalho, JS; Falcoff, E; Pedral-Sampaio, D; Silva, L	1
Neva, FA	1
Baumann, RJ; Bitonti, AJ; Hanson, WL; McCann, PP; Sjoerdsma, A	1
Ghosh, AK; Ghosh, DK; Khan, S; Mahato, SB; Mukerji, K; Pal, BC	1
Bacellar, O; Badaro, R; Barral, A; Carvalho, EM; Johnson, WD	1
Coutellier, P; Delgrange, B	1
Brahmachari, UN	2
Chulay, JD; Fleckenstein, L; Smith, DH	1
Baillie, AJ; Coombs, GH; Dolan, TF; Laurie, J	1
Baillie, AJ; Coombs, GH; Dolan, TF; Hunter, CA; Laakso, T; Sjöholm, I; Stjärnkvist, P	1
Baillie, AJ; Coombs, GH; Dolan, TF; Hunter, CA	1
Bonventre, PF; Nickol, AD	2
Dupic, Y; Goutner, C; Massip, P; Navarrot, P	1
Anciaux, ML; Bourée, P; Taugourdeau, P	1
Tsetentis, Y	1
De Caluwé, JP; Delcourt, A; Heimann, R; Lievens, P; Taelman, H; Trolin, C	1
Badaro, R	1
Hiçsönmez, G; Jama, H; Ozsoylu, S	1
Alvar, J; González-Lahoz, JM; Polo, RM; Verdejo, J	1
Ayats, R; Cadafalch, J; Orta, C; Portus, M	1
Gutiérrez Rodero, F	1
Davis, JS; De Alencar, JE; Evans, T; Naidu, TG; Pearson, RD; Wheeler, DA	1
Ben Rachid, MS; Ben Said, M	1
Badaró, R; Carvalho, EM; Johnson, WD; Jones, TC; Reed, SG	1
Adinolfi, LE; Bonventre, PF	1
Chapman, WL; Hanson, WL; Madindou, TJ	1
Adinolfi, LE; Bonventre, PF; Eppstein, DA; Vander Pas, M	1
Gutiérrez Rodero, F; Moya Jeromini, I; Ortiz de la Tabla Ducasse, V; Pozuelo González, A	1
Ben Salah, N; Katlama, C; Pichard, E; Régnier, B; Vachon, F	1
Andreoli, A; Bonora, G; Cambiè, M; Gargantini, G; Giaracuni, G; Manzoni, D; Perletti, L	1
Limbos, P; Van Ros, G	1
Bray, RS	1
Bhattacharyya, S; Khan, KP; Mukherjee, AM	1
Manson-Bahr, PE	1
Chapman, RL	1
Kern, F; Pedersen, JK	1
D'Agata, A; Musumeci, S; Romeo, M	1
Cascio, G	1
Lapierre, J	1
Hicsönmez, G; Ozsoylu, S	1
Paloucek, JT; Yaeger, RG; Zavoral, JH	1
Cousin, J; Ducoulombier, H; Duhamel, M; Fournier, A; Henninot, E	1
Barua, P; Jain, SC; Lyngdoh, E	1
Inferrera, C; Princi, P	1
Malamos, B	1
Kisler, HJ; Meier, E	1
Stanisic, M; Treske, U	1
Jalayer, T; Tahernia, AC	1
Meuwissen, OJ; van der Linde, DL; van Gorp, LH	1

Reviews

28 review(s) available for antimony and Leishmaniasis, Visceral

Article	Year
Amphotericin B: A drug of choice for Visceral Leishmaniasis. Acta tropica, 2022, Volume: 235 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Humans; Leishmania; Leishmania donovani; Leishmaniasis, Visceral; Liposomes	2022
Probing the molecular mechanism of aggressive infection by antimony resistant Leishmania donovani. Cytokine, 2021, Volume: 145 Topics: Animals; Antimony; Argonaute Proteins; Drug Resistance; Gene Expression Regulation; Humans; Leishmania donovani; Leishmaniasis, Visceral; Protozoan Proteins	2021
Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis. PLoS neglected tropical diseases, 2021, Volume: 15, Issue:3 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Deoxycholic Acid; Drug Combinations; Humans; Leishmaniasis, Visceral; Phosphorylcholine	2021
Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison. PLoS neglected tropical diseases, 2013, Volume: 7, Issue:5 Topics: Adolescent; Adult; Aged; Amphotericin B; Antimony; Antiprotozoal Agents; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Survival Analysis; Treatment Outcome; Young Adult	2013
PKDL--a drug related phenomenon? The Indian journal of medical research, 2008, Volume: 128, Issue:1 Topics: Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral	2008
Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens? Critical reviews in microbiology, 2013, Volume: 39, Issue:4 Topics: Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania donovani; Leishmaniasis, Visceral	2013
Clinical aspects of visceral leishmaniasis in HIV infection. Current opinion in infectious diseases, 2013, Volume: 26, Issue:1 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Antiprotozoal Agents; Clinical Trials as Topic; Humans; Leishmaniasis, Visceral; Serologic Tests	2013
Treatment of leishmaniasis in HIV-positive patients. Annals of tropical medicine and parasitology, 2003, Volume: 97 Suppl 1 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Antiprotozoal Agents; Drug Therapy, Combination; HIV Seropositivity; Humans; Interferon-gamma; Leishmaniasis, Visceral; Liposomes; Phospholipids; Recurrence	2003
Visceral leishmaniasis (kala-azar) and pregnancy. Infectious diseases in obstetrics and gynecology, 2004, Volume: 12, Issue:1 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Leishmaniasis, Visceral; Pregnancy; Pregnancy Complications, Parasitic	2004
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis. Expert review of anti-infective therapy, 2004, Volume: 2, Issue:2 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Drug Costs; Humans; Leishmaniasis, Visceral; Paromomycin; Phosphatidylcholines; Phosphatidylglycerols; Phosphorylcholine; Practice Guidelines as Topic	2004
[Visceral leishmaniases]. La Revue du praticien, 2004, Dec-31, Volume: 54, Issue:20 Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Brazil; Child, Preschool; Dogs; Ethiopia; Europe; Humans; Incidence; India; Infant; Infant, Newborn; Leishmaniasis, Visceral; Phosphorylcholine; Prevalence; Time Factors; Zoonoses	2004
Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. The Lancet. Infectious diseases, 2005, Volume: 5, Issue:12 Topics: Animals; Antimony; Antiprotozoal Agents; Child; Clinical Trials as Topic; Drug Resistance; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Randomized Controlled Trials as Topic; Treatment Outcome	2005
Visceral leishmaniasis (kala-azar): challenges ahead. The Indian journal of medical research, 2006, Volume: 123, Issue:3 Topics: Aminoquinolines; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Humans; India; Leishmania; Leishmaniasis, Visceral; Lipids; Paromomycin; Public Health; Sensitivity and Specificity	2006
[Treatment of visceral leishmaniasis in children]. Medecine tropicale : revue du Corps de sante colonial, 2007, Volume: 67, Issue:1 Topics: Amphotericin B; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine	2007
The chemotherapy of protozoal infections: whither? The Journal of protozoology, 1981, Volume: 28, Issue:1 Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Disease Models, Animal; Glycolipids; Humans; Leishmaniasis; Leishmaniasis, Visceral; Liposomes; Lysosomes; Malaria; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Primaquine; Protozoan Infections; Trypanosomiasis	1981
[Kala-azar. Presentation of 7 cases and review of the literature]. Anales espanoles de pediatria, 1984, Oct-31, Volume: 21, Issue:6 Topics: Antimony; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Metronidazole; Organometallic Compounds; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1984
[Leishmaniasis and human immunodeficiency virus infections]. Presse medicale (Paris, France : 1983), 1995, Jun-17, Volume: 24, Issue:22 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Female; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Male	1995
Visceral leishmaniasis: more prevalent and more problematic. The Journal of infection, 1994, Volume: 29, Issue:3 Topics: Allopurinol; Amphotericin B; Antimony; Humans; Immunity, Cellular; Leishmaniasis, Visceral; Opportunistic Infections	1994
Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 19, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Antimony; Duodenum; Gastric Mucosa; Gastrointestinal Diseases; Humans; Intestinal Mucosa; Leishmania; Leishmaniasis, Visceral; Male; Middle Aged; Pentamidine	1994
The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis. The Journal of infectious diseases, 1993, Volume: 167 Suppl 1 Topics: Antimony; Humans; Interferon-gamma; Leishmaniasis, Diffuse Cutaneous; Leishmaniasis, Visceral	1993
[Visceral leishmaniasis refractory to treatment: the efficacy of amphotericin B]. Anales espanoles de pediatria, 1996, Volume: 44, Issue:2 Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antimony; Antiprotozoal Agents; Child, Preschool; Chronic Disease; Drug Resistance; Humans; Leishmania donovani; Leishmaniasis, Visceral; Male; Roma; Spain	1996
Leishmaniasis. Lancet (London, England), 1999, Oct-02, Volume: 354, Issue:9185 Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Administration Schedule; Female; HIV Infections; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Male	1999
[Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection]. Anales de medicina interna (Madrid, Spain : 1984), 2000, Volume: 17, Issue:10 Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Fatal Outcome; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Substance Abuse, Intravenous	2000
Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2000, Volume: 4, Issue:3 Topics: Adult; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Child; Humans; Leishmania donovani; Leishmaniasis, Visceral; Mice; Paromomycin; Phosphorylcholine; Treatment Outcome	2000
Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient. Nephron, 1992, Volume: 60, Issue:3 Topics: Adult; Allopurinol; Animals; Antimony; Antiprotozoal Agents; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Methylprednisolone; Muromonab-CD3; Organometallic Compounds	1992
[A case report of visceral leishmaniasis]. Vutreshni bolesti, 1991, Volume: 30, Issue:2 Topics: Adult; Antimony; Antimony Sodium Gluconate; Humans; Leishmaniasis, Visceral; Male	1991
[Visceral kala-azar of Spanish origin. Apropos of a case]. Acta clinica Belgica, 1988, Volume: 43, Issue:5 Topics: Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	1988
Leishmaniasis in the Old World. British medical bulletin, 1972, Volume: 28, Issue:1 Topics: Africa; Anemia; Animals; Antibodies; Antimony; Carrier State; Climate; Disease Reservoirs; Erythromycin Ethylsuccinate; Humans; Immunoglobulin G; India; Insect Vectors; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Mice; Phlebotomus; Serum Albumin; Sudan	1972

Trials

11 trial(s) available for antimony and Leishmaniasis, Visceral

Article	Year
Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study. The American journal of tropical medicine and hygiene, 2002, Volume: 66, Issue:2 Topics: Adolescent; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; India; Leishmaniasis, Visceral; Male; Treatment Outcome	2002
Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:1 Topics: Adolescent; Adult; Aged; Amebicides; Amphotericin B; Animals; Anti-Bacterial Agents; Antimony; Child; Child, Preschool; Drug Administration Schedule; Drug Carriers; Female; Humans; Infant; Leishmania donovani; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Lymph Nodes; Male; Middle Aged; Paromomycin; Recurrence; Spleen; Sudan	1995
Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis. The Journal of infectious diseases, 1995, Volume: 171, Issue:4 Topics: Adolescent; Adult; Animals; Antimony; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Interferon-gamma; Leishmania donovani; Leishmaniasis, Visceral; Male; Middle Aged; Recombinant Proteins; Spleen	1995
Treatment of Mediterranean visceral leishmaniasis. Bulletin of the World Health Organization, 1995, Volume: 73, Issue:2 Topics: Adolescent; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Europe; Humans; Infant; Leishmaniasis, Visceral; Liposomes; Mediterranean Islands; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1995
Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis. The Journal of infectious diseases, 1994, Volume: 170, Issue:2 Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Health Care Costs; Humans; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Neutropenia; Organometallic Compounds; Pilot Projects; Recombinant Proteins; Severity of Illness Index	1994
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. The American journal of medicine, 1996, Volume: 100, Issue:5 Topics: Adult; Aged; Allopurinol; Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Data Interpretation, Statistical; Female; Follow-Up Studies; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Multivariate Analysis; Organometallic Compounds; Recurrence; Retrospective Studies; Time Factors	1996
Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Annals of internal medicine, 1997, Jul-15, Volume: 127, Issue:2 Topics: Adolescent; Adult; Amphotericin B; Anti-Bacterial Agents; Antimony; Drug Administration Schedule; Drug Carriers; Female; Follow-Up Studies; Humans; Leishmaniasis, Visceral; Lipids; Male; Treatment Outcome	1997
Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis. The Journal of infectious diseases, 1997, Volume: 176, Issue:4 Topics: Adolescent; Adult; Aged; Antimony; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; India; Interferon-gamma; Leishmaniasis, Visceral; Male; Middle Aged; Recombinant Proteins	1997
Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex. Annals of tropical medicine and parasitology, 1998, Volume: 92, Issue:7 Topics: Adolescent; Adult; Amphotericin B; Analysis of Variance; Antimony; Antiprotozoal Agents; Child; Cost-Benefit Analysis; Drug Combinations; Drug Resistance; Female; Humans; India; Leishmaniasis, Visceral; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Single-Blind Method	1998
Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis. The Journal of the Association of Physicians of India, 1999, Volume: 47, Issue:2 Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Antimony; Chi-Square Distribution; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leishmaniasis, Visceral; Male; Phosphatidylcholines; Phosphatidylglycerols; Probability; Treatment Outcome	1999
The treatment of kala-azar: old and new options. Tropical and geographical medicine, 1992, Volume: 44, Issue:3 Topics: Amphotericin B; Antimony; Humans; Ketoconazole; Leishmaniasis, Visceral; Paromomycin	1992

Other Studies

233 other study(ies) available for antimony and Leishmaniasis, Visceral

Article	Year
Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients. Frontiers in cellular and infection microbiology, 2022, Volume: 12 Topics: Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmaniasis, Visceral; Membrane Transport Proteins; Sulfhydryl Compounds	2022
Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 05-18, Volume: 72, Issue:10 Topics: Antimony; Antiprotozoal Agents; Aquaglyceroporins; DNA Copy Number Variations; Drug Resistance; Humans; Leishmania donovani; Leishmaniasis, Visceral; Mutation	2021
The drug resistance mechanisms in Leishmania donovani are independent of immunosuppression. Cytokine, 2021, Volume: 145 Topics: Amphotericin B; Animals; Antimony; Cytokines; Drug Resistance; Immunosuppression Therapy; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Phosphorylcholine; Protozoan Proteins	2021
Integrative genomic, proteomic and phenotypic studies of Leishmania donovani strains revealed genetic features associated with virulence and antimony-resistance. Parasites & vectors, 2020, Oct-12, Volume: 13, Issue:1 Topics: Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Gene Expression Profiling; Genes, Protozoan; Genome, Protozoan; Host-Parasite Interactions; Humans; Leishmania donovani; Leishmaniasis, Visceral; Phenotype; Proteome; Protozoan Proteins; Virulence	2020
Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani. International journal for parasitology. Drugs and drug resistance, 2017, Volume: 7, Issue:3 Topics: Amlodipine; Animals; Anti-Bacterial Agents; Antimony; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Drug Resistance; Gene Expression Profiling; Humans; Leishmania donovani; Leishmaniasis, Visceral; Life Cycle Stages; Macrophages; Metabolic Networks and Pathways; Mice; Nitric Oxide; Parasitic Sensitivity Tests; Paromomycin; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Verapamil	2017
Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies. Parasitology, 2018, Volume: 145, Issue:4 Topics: Adolescent; Adult; Aged; Animals; Antimony; Child; Child, Preschool; Clinical Studies as Topic; Cytokines; Follow-Up Studies; Humans; Infant; Interferon-gamma; Interleukin-10; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Lymph Nodes; Macrophages; Male; Mice; Mice, Inbred BALB C; Middle Aged; Skin; Spleen; Sri Lanka; Virulence; Young Adult	2018
Increased thiol levels in antimony-resistant Leishmania infantum isolated from treatment-refractory visceral leishmaniasis in Brazil. Memorias do Instituto Oswaldo Cruz, 2018, Volume: 113, Issue:2 Topics: Antimony; Buthionine Sulfoximine; Drug Resistance; Enzyme Inhibitors; Humans; Leishmania infantum; Leishmaniasis, Visceral; Microscopy, Electron, Transmission; Parasitic Sensitivity Tests; Sulfhydryl Compounds	2018
Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria. PLoS neglected tropical diseases, 2018, Volume: 12, Issue:3 Topics: Algeria; Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Dogs; Drug Resistance; Humans; Inhibitory Concentration 50; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Psychodidae; Rodentia	2018
Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent. mSphere, 2018, 04-25, Volume: 3, Issue:2 Topics: Antimony; Antimony Potassium Tartrate; Antiprotozoal Agents; Drug Resistance; Genetic Variation; Genomics; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Metabolomics; Nepal; Protozoan Proteins	2018
Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania Vaccine, 2013, Apr-08, Volume: 31, Issue:15 Topics: Animals; Antimony; Cricetinae; Cross-Priming; Cytokines; Drug Resistance; Female; Immunity, Cellular; Immunity, Humoral; Leishmania donovani; Leishmaniasis, Visceral; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Protozoan Proteins; Protozoan Vaccines; T-Lymphocytes; Vaccination; Vaccines, DNA; Vaccinia virus	2013
Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines. Journal of medicinal chemistry, 2014, Jun-26, Volume: 57, Issue:12 Topics: Animals; Antimony; Cell Line; Diamines; Drug Resistance; Leishmania; Leishmania donovani; Leishmania mexicana; Leishmaniasis, Visceral; Macrophages; Male; Mice, Inbred BALB C; Quinazolines; Structure-Activity Relationship; Trypanocidal Agents	2014
Association of liposome-encapsulated trivalent antimonial with ascorbic acid: an effective and safe strategy in the treatment of experimental visceral leishmaniasis. PloS one, 2014, Volume: 9, Issue:8 Topics: Animals; Antimony; Ascorbic Acid; Flow Cytometry; Immunophenotyping; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Mice; Mice, Inbred BALB C; Parasite Load; Statistics, Nonparametric	2014
Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection. Journal of immunology (Baltimore, Md. : 1950), 2014, Oct-15, Volume: 193, Issue:8 Topics: Acetylation; Animals; Antibodies; Antimony; Antimony Sodium Gluconate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Cricetinae; Drug Resistance; Histone Deacetylase 6; Histone Deacetylases; Imipramine; Interleukin-10; Interleukin-12; Interleukin-12 Subunit p35; Interleukin-12 Subunit p40; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; NF-kappa B p50 Subunit; Promoter Regions, Genetic; Signal Transduction; T-Lymphocytes; Transcription Factor RelA; Trypanocidal Agents	2014
The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India. Parasites & vectors, 2014, Dec-17, Volume: 7 Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Glutamate-Cysteine Ligase; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Membrane Transport Proteins; Mutation; Phosphorylcholine; Protozoan Proteins; Sulfhydryl Compounds	2014
Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging. PLoS neglected tropical diseases, 2015, Volume: 9, Issue:2 Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Humans; India; Leishmania infantum; Leishmaniasis, Visceral; Luciferases; Parasite Load; Phosphorylcholine; Recombinant Proteins	2015
Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1. PLoS neglected tropical diseases, 2015, Volume: 9, Issue:2 Topics: 3' Untranslated Regions; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Aquaglyceroporins; Aquaporin 1; Cell Movement; Drug Resistance; Gene Expression Regulation; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; RNA, Messenger; RNA, Protozoan	2015
MAPK1 of Leishmania donovani modulates antimony susceptibility by downregulating P-glycoprotein efflux pumps. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7 Topics: Antimony; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Caspase 3; DNA Fragmentation; Drug Resistance; Gene Knockout Techniques; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinase 1; Molecular Sequence Data; Phosphatidylserines; Reactive Oxygen Species	2015
Elevated ergosterol protects Leishmania parasites against antimony-generated stress. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2015, Volume: 29, Issue:10 Topics: Acetamides; Antimony; Antiprotozoal Agents; Cell Survival; DNA Fragmentation; Ergosterol; Fatty Acids; Gas Chromatography-Mass Spectrometry; Genetic Engineering; Hemolysis; Humans; Leishmania donovani; Leishmaniasis, Visceral; Oxidative Stress; Protective Agents; Reactive Oxygen Species	2015
A Multiplatform Metabolomic Approach to the Basis of Antimonial Action and Resistance in Leishmania infantum. PloS one, 2015, Volume: 10, Issue:7 Topics: Antimony; Antiprotozoal Agents; Chromatography, Liquid; Drug Resistance; Humans; Leishmania infantum; Leishmaniasis, Visceral; Metabolome; Metabolomics; Tandem Mass Spectrometry	2015
Antimony-Resistant Leishmania donovani Exploits miR-466i To Deactivate Host MyD88 for Regulating IL-10/IL-12 Levels during Early Hours of Infection. Journal of immunology (Baltimore, Md. : 1950), 2015, Sep-15, Volume: 195, Issue:6 Topics: 3' Untranslated Regions; Animals; Antimony; Cells, Cultured; Cricetinae; Drug Resistance; Interleukin-10; Interleukin-12 Subunit p35; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Myeloid Differentiation Factor 88; NF-kappa B; RNA Interference; RNA, Small Interfering; Toll-Like Receptor 2; Toll-Like Receptor 6	2015
Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages. Parasitology research, 2016, Volume: 115, Issue:2 Topics: Adult; Amphotericin B; Animals; Antimony; Cytokines; Drug Resistance; Drug Tolerance; Humans; Immune Tolerance; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Macrophages; Male; Mice; Middle Aged; Nitric Oxide; Nitrites; Recurrence; Spleen	2016
In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization. Molecular microbiology, 2016, Volume: 99, Issue:6 Topics: Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Female; Leishmania donovani; Leishmaniasis, Visceral; Lipid Metabolism; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Mutation; Nepal; Parasitic Sensitivity Tests; Phosphorylcholine	2016
Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B. PLoS neglected tropical diseases, 2016, Volume: 10, Issue:1 Topics: Adult; Aged; Amphotericin B; Antimony; Antiprotozoal Agents; Female; Humans; Infant; Leishmania donovani; Leishmaniasis, Visceral; Male; Middle Aged; Treatment Outcome	2016
Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent. eLife, 2016, Mar-22, Volume: 5 Topics: Antimony; Antiprotozoal Agents; Aquaporin 1; Drug Resistance; Epidemics; Evolution, Molecular; Genetic Variation; Genome, Protozoan; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Molecular Epidemiology; Nepal; Recombination, Genetic; Sequence Analysis, DNA	2016
Pi inhibits intracellular accumulation of methylglyoxal in promastigote form of L. donovani. Molecular and biochemical parasitology, 2016, Volume: 207, Issue:2 Topics: Animals; Antimony; Glucose; Inactivation, Metabolic; Leishmania donovani; Leishmaniasis, Visceral; Phosphate Transport Proteins; Phosphates; Pyruvaldehyde	2016
Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum. International journal for parasitology. Drugs and drug resistance, 2016, Volume: 6, Issue:2 Topics: Animals; Antimony; Antiprotozoal Agents; Aquaglyceroporins; Dog Diseases; Dogs; Drug Resistance; Gene Expression; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Sulfhydryl Compounds	2016
Genetic markers for antimony resistant clinical isolates differentiation from Indian Kala-azar. Acta tropica, 2016, Volume: 164 Topics: Antimony; Antiprotozoal Agents; Bangladesh; Bone Marrow; Cluster Analysis; DNA, Protozoan; Drug Resistance; Gene Expression Regulation; Genes, Protozoan; Genetic Markers; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Male; Middle Aged; Molecular Sequence Data; Phylogeny; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA	2016
Functionality of drug efflux pumps in antimonial resistant Leishmania donovani field isolates. Indian journal of biochemistry & biophysics, 2009, Volume: 46, Issue:1 Topics: Adenosine Triphosphate; Animals; Antimony; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Drug Resistance, Multiple; Fluoresceins; Humans; Leishmania donovani; Leishmaniasis, Visceral; Multidrug Resistance-Associated Proteins; Ofloxacin; Probenecid; Protozoan Proteins; Rhodamine 123; Verapamil	2009
Antimony containing drug and ECG abnormalities in children with visceral leishmaniasis. Biological trace element research, 2009, Volume: 132, Issue:1-3 Topics: Antimony; Antiprotozoal Agents; Cardiovascular Abnormalities; Child; Child, Preschool; Electrocardiography; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2009
Ubiquitin conjugation of open reading frame F DNA vaccine leads to enhanced cell-mediated immune response and induces protection against both antimony-susceptible and -resistant strains of Leishmania donovani. Journal of immunology (Baltimore, Md. : 1950), 2009, Dec-15, Volume: 183, Issue:12 Topics: Animals; Antimony; Cells, Cultured; Drug Resistance; Female; Genetic Predisposition to Disease; Immunity, Cellular; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Open Reading Frames; Protozoan Proteins; Th1 Cells; Ubiquitin; Vaccines, Conjugate; Vaccines, DNA	2009
Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:3 Topics: Amino Acid Sequence; Antimony; Antiprotozoal Agents; Aquaporin 1; DNA, Protozoan; Drug Resistance; Gene Expression Profiling; Genes, Protozoan; Humans; India; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Models, Biological; Models, Molecular; Molecular Sequence Data; Parasitic Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Sequence Alignment; Sequence Analysis, DNA; Transfection	2010
A case of kala-azar treated with a new antimony. Lyon medical, 1947, May-18, Volume: 177, Issue:20 Topics: Antimony; Humans; Leishmaniasis, Visceral	1947
Sodium antimony v. gluconate in the treatment of Indian kala-azar. The Indian medical gazette, 1946, Volume: 81, Issue:11 Topics: Antimony; Antimony Sodium Gluconate; Asian People; Humans; Leishmaniasis; Leishmaniasis, Visceral; Sodium	1946
Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates. Molecular and biochemical parasitology, 2010, Volume: 173, Issue:2 Topics: Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania donovani; Leishmaniasis, Visceral; Peroxidases; Peroxides; Protozoan Proteins; Thioredoxins	2010
A new sodium antimony gluconate for the treatment of kala-azar. Journal of the Indian Medical Association, 1945, Volume: 14 Topics: Antimony; Gluconates; Humans; Leishmaniasis; Leishmaniasis, Visceral; Sodium	1945
The treatment of kala-azar with sodium antimony-v-gluconate; preliminary observations. The Indian medical gazette, 1945, Volume: 80 Topics: Antimony; Antimony Sodium Gluconate; Gluconates; Humans; Leishmaniasis; Leishmaniasis, Visceral; Sodium; Stomach	1945
On the toxicity of some organic antimonial drugs used for the treatment of kala-azar. The Indian medical gazette, 1946, Volume: 81 Topics: Antimony; Leishmaniasis; Leishmaniasis, Visceral	1946
Drug susceptibility of Leishmania infantum (syn. Leishmania chagasi) isolates from Brazilian HIV-positive and HIV-negative patients. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:3 Topics: Antimony; Antiprotozoal Agents; Brazil; HIV Infections; Humans; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Parasitic Sensitivity Tests	2011
Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent? PLoS neglected tropical diseases, 2011, Volume: 5, Issue:9 Topics: Antimony; Antiprotozoal Agents; Arsenic; Drug Resistance; Humans; India; Leishmania; Leishmania donovani; Leishmania infantum; Leishmaniasis, Visceral; Poisons; Treatment Failure	2011
Downregulation of mitogen-activated protein kinase 1 of Leishmania donovani field isolates is associated with antimony resistance. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Antimony; Antiprotozoal Agents; Down-Regulation; Drug Resistance; Escherichia coli; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Humans; India; Kinetics; Leishmania donovani; Leishmaniasis, Visceral; Mitogen-Activated Protein Kinase 1; Myelin Sheath; Oligonucleotide Array Sequence Analysis; Parasitic Sensitivity Tests; Protozoan Proteins; Real-Time Polymerase Chain Reaction; Recombinant Proteins; Staurosporine	2012
Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2012, Volume: 12, Issue:1 Topics: Africa; Antimony; Asia; DNA, Protozoan; Drug Resistance; Europe; Genetic Loci; Genome, Protozoan; Genotype; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Microsatellite Repeats; Phylogeny; Phylogeography; Polymorphism, Single Nucleotide	2012
Serological monitoring of paediatric visceral leishmaniasis By IFA and ELISA methods. Turkiye parazitolojii dergisi, 2011, Volume: 35, Issue:3 Topics: Adolescent; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; DNA, Protozoan; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Infant; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Turkey	2011
Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:4 Topics: Animals; Antimony; Antiprotozoal Agents; Disease Models, Animal; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Female; Leishmania donovani; Leishmaniasis, Visceral; Liver; Macrophages; Mice; Mice, Inbred BALB C; Microscopy; Nitric Oxide; Polymerase Chain Reaction; Spleen; Treatment Outcome; Triterpenes; Tumor Necrosis Factor-alpha	2012
Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani. Parasitology research, 2012, Volume: 111, Issue:1 Topics: Antimony; Antiprotozoal Agents; Biomarkers; Drug Resistance; Gene Expression Profiling; Humans; Leishmania donovani; Leishmaniasis, Visceral; Protozoan Proteins; Real-Time Polymerase Chain Reaction	2012
Leishmania strains causing self-healing cutaneous leishmaniasis have greater susceptibility towards oxidative stress. Free radical research, 2012, Volume: 46, Issue:5 Topics: Antimony; Free Radicals; Humans; Leishmania major; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Macrophages; Nitric Oxide; Oxidative Stress; Phosphorylcholine; Superoxide Dismutase	2012
Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background. PLoS neglected tropical diseases, 2012, Volume: 6, Issue:2 Topics: Animals; Antimony; Antiprotozoal Agents; Child; Child, Preschool; DNA, Protozoan; Drug Resistance; Gene Expression Profiling; Genetic Variation; Humans; Leishmania donovani; Leishmaniasis, Visceral; Nepal; Protozoan Proteins	2012
Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol. PLoS neglected tropical diseases, 2012, Volume: 6, Issue:5 Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Drug Resistance; Genomic Instability; Humans; India; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis, Visceral; Mesocricetus; Mice; Mice, Inbred BALB C; Nepal; Parasitic Sensitivity Tests; Parasitology; Paromomycin; Selection, Genetic; Serial Passage	2012
Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India. Parasitology research, 2012, Volume: 111, Issue:4 Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Drug Resistance; Female; Genotype; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Male; Microsatellite Repeats; Middle Aged; Polymorphism, Genetic; Young Adult	2012
Development of luciferase expressing Leishmania donovani axenic amastigotes as primary model for in vitro screening of antileishmanial compounds. Current microbiology, 2012, Volume: 65, Issue:6 Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Culture Media; Drug Evaluation, Preclinical; Humans; Leishmania donovani; Leishmaniasis, Visceral; Luciferases; Parasitic Sensitivity Tests	2012
Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India. PLoS neglected tropical diseases, 2012, Volume: 6, Issue:12 Topics: Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Humans; India; Leishmaniasis, Visceral; Models, Theoretical; Psychodidae; Treatment Failure	2012
Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection. PLoS neglected tropical diseases, 2012, Volume: 6, Issue:12 Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Drug Resistance; Imipramine; Leishmania donovani; Leishmaniasis, Visceral; Parasitic Sensitivity Tests; Treatment Outcome	2012
Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infection and immunity, 2002, Volume: 70, Issue:11 Topics: Animals; Antimony; Granuloma; Immunotherapy; Interleukin-10; Interleukin-12; Interleukin-4; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Mice, Knockout; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Receptors, Interleukin; Receptors, Interleukin-10; Recurrence	2002
Epiglottis involvement in a visceral leishmaniasis. The Journal of infection, 2002, Volume: 45, Issue:3 Topics: Adult; Animals; Antimony; DNA, Protozoan; Epiglottis; Hepatomegaly; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Splenomegaly	2002
RBC-associated IgG in patients with visceral leishmaniasis (kala-azar): a prospective analysis. Transfusion, 2002, Volume: 42, Issue:11 Topics: Anemia; Anemia, Hemolytic, Autoimmune; Antibody Specificity; Antimony; Coombs Test; Erythrocytes; Hemagglutination Tests; Humans; Immunoglobulin G; Leishmaniasis, Visceral; Liver Diseases; Prospective Studies	2002
Dendritic cell-based immunotherapy combined with antimony-based chemotherapy cures established murine visceral leishmaniasis. Journal of immunology (Baltimore, Md. : 1950), 2003, Jun-01, Volume: 170, Issue:11 Topics: Adoptive Transfer; Animals; Antigen-Presenting Cells; Antigens, Protozoan; Antimony; Antiprotozoal Agents; Combined Modality Therapy; Dendritic Cells; Injections, Intramuscular; Injections, Intravenous; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Protozoan Vaccines; Solubility; Th1 Cells	2003
[N-methylglucamine antimoniate in the treatment of visceral leishmaniasis; first cases treated in Spain]. Revista cubana de pediatria, 1952, Volume: 24, Issue:7 Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain	1952
Treatment of post-kala-azar dermal leishmaniasis with methyl glucamine antimoniate. The Journal of tropical medicine and hygiene, 1952, Volume: 55, Issue:9 Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral	1952
[Note on the use of drugs with antimony base; a case of kala-azar treated with glucantime]. Archives francaises de pediatrie, 1954, Volume: 11, Issue:6 Topics: Antimony; Hypersensitivity; Immune System Diseases; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1954
Agranulocytosis following antimony therapy in kala-azar. Journal of the Indian Medical Association, 1955, Oct-16, Volume: 25, Issue:10 Topics: Agranulocytosis; Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral	1955
[Two cases of kala-azar treated with glucantime]. Acta pediatrica espanola, 1955, Volume: 13, Issue:155 Topics: Antimony; Child; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1955
[Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives: personal observation]. El Dia medico, 1956, Nov-15, Volume: 28, Issue:84 Topics: Antimony; Gluconates; Humans; Leishmaniasis; Leishmaniasis, Visceral	1956
[Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives]. Revista medica de Cordoba, 1956, Volume: 44 Topics: Antimony; Gluconates; Humans; Leishmaniasis; Leishmaniasis, Visceral	1956
[Toxic nephritis during the course of antimony treatment of kala-azar]. Concours medical, 1957, Jun-15, Volume: 79, Issue:24 Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Nephritis	1957
[Test treatment with N-methylglucamine antimoniate in the diagnosis of kala-azar in children]. Hospital (Rio de Janeiro, Brazil), 1958, Volume: 54, Issue:3 Topics: Antimony; Child; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1958
[8 cases of kala-azar cured with glucantime]. Acta pediatrica espanola, 1962, Volume: 20 Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1962
[Azotemic nephritis during antimony therapy of a case of infantile visceral leishmaniasis]. Maroc medical, 1962, Volume: 41 Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Nephritis; Uremia; Urologic Diseases	1962
[IMPORTANCE OF LYMPH NODE BIOPSY IN THE DIAGNOSIS OF KALA-AZAR IN THE ADULT]. Bulletins et memoires de la Societe medicale des hopitaux de Paris, 1963, May-31, Volume: 114 Topics: Adult; Antimony; Biopsy; Blood Protein Disorders; Blood Protein Electrophoresis; Diagnosis; Humans; Leishmaniasis; Leishmaniasis, Visceral; Lymph Nodes; Prednisone; Splenomegaly	1963
THE HUMAN TRYPANOSOMATIDAE. III. LEISHMANIASIS: KALA-AZAR. New York state journal of medicine, 1963, Dec-01, Volume: 63 Topics: Amidines; Antimony; Child; DDT; Dental Prophylaxis; Hexachlorocyclohexane; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Nutritional Physiological Phenomena; Nutritional Sciences; Pathology; Toxicology; Trypanosomatina	1963
KALA-AZAR IN WISCONSIN, CASE REPORT. The American journal of gastroenterology, 1963, Volume: 40 Topics: Antimony; Blood Proteins; Blood Sedimentation; Complement Fixation Tests; Humans; Leishmaniasis; Leishmaniasis, Visceral; Leukocyte Count; Liver Function Tests; Spleen; Splenectomy; Wisconsin	1963
[CONTRIBUTION TO THE KNOWLEDGE OF VISCERAL LEISHMANIASIS OF THE ADULT]. La Riforma medica, 1963, Nov-16, Volume: 77 Topics: Adult; Anti-Bacterial Agents; Antimony; Bone Marrow Examination; Chloramphenicol; Diagnosis; Electrocardiography; Epidemiology; Humans; Italy; Leishmaniasis; Leishmaniasis, Visceral; Protein Synthesis Inhibitors; Punctures; Sternum; Tetracycline	1963
[KALA-AZAR]. La Medecine infantile, 1964, Volume: 71 Topics: Adolescent; Aging; Antimony; Antiprotozoal Agents; Biopsy; Blood Cell Count; Blood Protein Disorders; Bone Marrow Examination; Child; Diagnosis; Epidemiology; Fever; France; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Liver; Lymph Nodes; Pallor; Spleen; Splenomegaly	1964
[LEISHMANIASIS AS ENCOUNTERED IN FRANCE. CLINICAL AND THERAPEUTIC ASPECTS]. La Revue du praticien, 1964, Mar-21, Volume: 14 Topics: Amidines; Antimony; Blood Protein Electrophoresis; Clinical Laboratory Techniques; Diagnosis; Epidemiology; France; Humans; Leishmaniasis; Leishmaniasis, Visceral	1964
A REVIEW OF KALA-AZAR IN MALTA FROM 1947 TO 1962. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1964, Volume: 58 Topics: Anemia; Antimony; Blood Transfusion; Bone Marrow Examination; Child; Diagnosis, Differential; Dietary Proteins; Epidemiology; Humans; Insecticides; Leishmaniasis; Leishmaniasis, Visceral; Malta; Mediterranean Islands	1964
CHEMOTHERAPY OF TROPICAL DISEASES. Current medicine and drugs, 1964, Volume: 4, Issue:10 Topics: Amebiasis; Amebicides; Anti-Bacterial Agents; Antimalarials; Antimony; Arsenicals; Chagas Disease; Chloroquine; Dysentery, Amebic; Emetine; Humans; Iodoquinol; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Malaria; Suramin; Trypanosomiasis; Trypanosomiasis, African; United States	1964
LEISHMANIASIS IN THE SUDAN REPUBLIC. XXI. INFECTION IN AMERICAN PERSONNEL. The American journal of tropical medicine and hygiene, 1964, Volume: 13 Topics: Africa; Africa, Eastern; Antimony; Drug Therapy; Epidemiology; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Pathology; Skin Tests; Sudan; United States	1964
LEISHMANIASIS IN THE SUDAN REPUBLIC (26). ELECTROCARDIOGRAPHIC FINDINGS IN SUDANESE KALA-AZAR. East African medical journal, 1965, Volume: 42 Topics: Africa; Africa, Eastern; Antimony; Black People; Electrocardiography; Humans; Leishmaniasis; Leishmaniasis, Visceral; Sudan	1965
[N-methylglucamine antimoniate (glucantime) in therapy of infantile visceral leishmaniasis; a further case of autocthonous infantile visceral leishmaniasis on the island of Elba]. Minerva dermatologica, 1955, Volume: 30, Issue:4 Topics: Antimony; Humans; Islands; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1955
[The current status of the problem of visceral leishmaniasis]. Meditsinskii zhurnal Uzbekistana, 1961, Volume: 8 Topics: Antimony; Humans; Leishmaniasis, Visceral	1961
[Therapy of visceral leishmaniasis with n-methyl-glucamine antimoniate]. La Presse medicale, 1951, Nov-10, Volume: 59, Issue:71 Topics: Antimony; Leishmaniasis; Leishmaniasis, Visceral	1951
Treatment of Chinese kala-azar with sodium antimony gluconate. The Journal of tropical medicine and hygiene, 1949, Volume: 52, Issue:10 Topics: Antimony; Antimony Sodium Gluconate; Asian People; Humans; Leishmaniasis; Leishmaniasis, Visceral; Sodium	1949
[Our experience in the treatment of kala-azar]. Acta pediatrica espanola, 1950, Volume: 8, Issue:89 Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral	1950
Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India. The Indian journal of medical research, 2004, Volume: 120, Issue:3 Topics: Adult; Amphotericin B; Analysis of Variance; Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Drug Resistance; Humans; India; Leishmaniasis, Visceral; Male; Mice; Mice, Inbred BALB C; Spectrophotometry, Atomic	2004
Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds? International journal of antimicrobial agents, 2005, Volume: 25, Issue:1 Topics: Adolescent; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Female; Greece; Humans; Infant; Infant, Newborn; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2005
Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis. Acta tropica, 2005, Volume: 93, Issue:3 Topics: Animals; Antimony; Female; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Receptors, Interleukin	2005
Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: ev Journal of immunology (Baltimore, Md. : 1950), 2005, Jun-01, Volume: 174, Issue:11 Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimony; Cell Line; Cricetinae; Cytotoxicity, Immunologic; Drug Resistance; Humans; Immunoglobulin G; Interleukin-2; Interleukin-4; Leishmania donovani; Leishmaniasis, Visceral; Liver Diseases, Parasitic; Membrane Glycoproteins; Nitric Oxide Synthase; Protozoan Proteins; Reactive Nitrogen Species; Reactive Oxygen Species; Spleen; T-Lymphocytes, Cytotoxic; Th1 Cells; Th2 Cells; Vaccines, DNA	2005
Visceral leishmaniasis therapy. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Pentamidine	1989
Antimony-based antileishmanial compounds prolong the cardiac action potential by an increase in cardiac calcium currents. Molecular pharmacology, 2006, Volume: 69, Issue:4 Topics: Action Potentials; Antimony; Antiprotozoal Agents; Calcium; Cell Line; Ether-A-Go-Go Potassium Channels; Humans; Leishmaniasis, Visceral; Long QT Syndrome; Myocardium; Torsades de Pointes	2006
Antimony-induced cerebellar ataxia. Saudi medical journal, 2006, Volume: 27, Issue:1 Topics: Adult; Amphotericin B; Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cerebellar Ataxia; Electroencephalography; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Male; Sudan	2006
Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis. Acta tropica, 2006, Volume: 99, Issue:1 Topics: Adult; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Female; HIV; HIV Infections; Humans; Interleukin-15; Leishmania; Leishmaniasis, Visceral; Longitudinal Studies; Male	2006
Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani. Parasitology international, 2007, Volume: 56, Issue:1 Topics: Animals; Antimony; Antiprotozoal Agents; Blotting, Northern; Cell Membrane; Drug Resistance; Genes, Protozoan; Leishmania donovani; Leishmaniasis, Visceral; Membrane Proteins; Protozoan Proteins; RNA, Protozoan	2007
Drug policy for visceral leishmaniasis: a cost-effectiveness analysis. Tropical medicine & international health : TM & IH, 2007, Volume: 12, Issue:2 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Cost-Benefit Analysis; Decision Trees; Deoxycholic Acid; Drug Combinations; Endemic Diseases; Health Care Costs; Humans; Leishmaniasis, Visceral; Phosphorylcholine; Treatment Outcome	2007
Characterization of natural antimony resistance in Leishmania donovani isolates. The American journal of tropical medicine and hygiene, 2007, Volume: 76, Issue:4 Topics: Animals; Antimony; Antiprotozoal Agents; Buthionine Sulfoximine; Cells, Cultured; Drug Resistance; Gene Expression Regulation; Humans; Leishmania donovani; Leishmaniasis, Visceral; Sulfhydryl Compounds	2007
Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony. Parasitology, 2007, Volume: 134, Issue:Pt 12 Topics: Animals; Antimony; Antiparasitic Agents; Drug Resistance; Humans; Hydrogen Peroxide; Leishmania donovani; Leishmaniasis, Visceral; Reactive Oxygen Species; Species Specificity; Sulfhydryl Compounds	2007
[Demographic, clinical and therapeutic features of adult visceral leishmaniasis at the Rabta hospital in Tunis (tunisia) from 1983 to 2002]. Bulletin de la Societe de pathologie exotique (1990), 2007, Volume: 100, Issue:4 Topics: Adult; Amphotericin B; Anemia; Animals; Antimony; Antiprotozoal Agents; Fever; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Splenomegaly; Treatment Outcome; Tunisia	2007
[Visceral leishmaniasis (kala-azar): 1st case observed in Chile]. Revista medica de Chile, 1984, Volume: 112, Issue:3 Topics: Adult; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly	1984
Liposomes in leishmaniasis: effects of parasite virulence on treatment of experimental leishmaniasis in hamsters. Annals of tropical medicine and parasitology, 1984, Volume: 78, Issue:3 Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Leishmania; Leishmaniasis, Visceral; Liposomes; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Virulence	1984
Leishmania donovani: oral efficacy and toxicity of formycin B in the infected hamster. Experimental parasitology, 1983, Volume: 56, Issue:2 Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antimony; Bilirubin; Bone Marrow; Cricetinae; Drug Evaluation, Preclinical; Formycins; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds	1983
Liposomal chemotherapy in visceral leishmaniasis: an ultrastructural study of an intracellular pathway. Zeitschrift fur Parasitenkunde (Berlin, Germany), 1983, Volume: 69, Issue:4 Topics: Animals; Antimony; Cricetinae; Kupffer Cells; Leishmania; Leishmaniasis, Visceral; Liposomes; Lysosomes; Macrophages; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Microscopy, Electron; Organometallic Compounds; Phagocytosis; Spleen	1983
[A case of visceral leishmaniasis]. Revue medicale de Liege, 1984, Mar-15, Volume: 39, Issue:6 Topics: Aged; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1984
Cold agglutinin syndrome and hemophagocytosis in systemic leishmaniasis. Scandinavian journal of haematology, 1984, Volume: 32, Issue:4 Topics: Anemia, Hemolytic, Autoimmune; Antimony; Bone Marrow Cells; Child, Preschool; Histiocytes; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phagocytosis	1984
Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog. American journal of veterinary research, 1984, Volume: 45, Issue:5 Topics: Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmania; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1984
Relative insensitivity of a Kenyan strain of Leishmania donovani to pentavalent antimony therapy in hamsters. The Journal of parasitology, 1983, Volume: 69, Issue:2 Topics: Animals; Antimony; Cricetinae; Leishmania; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1983
[Kala-azar in childhood. 20 year review]. Anales espanoles de pediatria, 1983, Volume: 18, Issue:1 Topics: Adolescent; Age Factors; Aniline Compounds; Antimony; Bone Marrow; Child; Child, Preschool; Female; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sex Factors; Spain; Stilbenes	1983
Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro. The American journal of tropical medicine and hygiene, 1982, Volume: 31, Issue:3 Pt 1 Topics: Animals; Antimony; Drug Resistance; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Macrophages	1982
[Kala-azar and autoimmune hemolytic anemia. Apropos of a fatally developing case caused by hepatotoxicity from N-methylglucamine antimonate]. Revista clinica espanola, 1982, Mar-31, Volume: 164, Issue:6 Topics: Aged; Anemia, Hemolytic, Autoimmune; Antimony; Chemical and Drug Induced Liver Injury; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1982
Kala-azar in Afghanistan. The Journal of tropical medicine and hygiene, 1982, Volume: 85, Issue:5 Topics: Afghanistan; Antimony; Antiprotozoal Agents; Child, Preschool; Female; Hepatomegaly; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly	1982
[Kala-azar in childhood]. Harefuah, 1980, Volume: 98, Issue:11-12 Topics: Antimony; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Pentamidine	1980
Modifications of leucocyte function in visceral leishmaniasis. Bollettino dell'Istituto sieroterapico milanese, 1981, Jul-31, Volume: 60, Issue:3 Topics: Adult; Antimony; Antiprotozoal Agents; Blood Bactericidal Activity; Humans; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Middle Aged; Neutrophils; Phagocytosis	1981
[Adult Mediterranean visceral leishmaniasis: report of 12 cases (author's transl)]. Annales de medecine interne, 1980, Volume: 131, Issue:2 Topics: Adolescent; Adult; Aged; Antimony; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	1980
Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline. Life sciences, 1980, Jun-30, Volume: 26, Issue:26 Topics: Aminoquinolines; Animals; Antimony; Cricetinae; Leishmaniasis, Visceral; Liposomes; Tetracycline	1980
[Diagnosis and therapy of visceral leishmaniasis]. Monatsschrift fur Kinderheilkunde, 1980, Volume: 128, Issue:5 Topics: Antimony; Child, Preschool; Humans; Leishmaniasis, Visceral; Pentamidine; Recurrence	1980
Natural autoantibodies, IgG antibodies to tetanus toxoid and CD5+ B cells in patients with Mediterranean visceral leishmaniasis. The Leishmania Study Group. Clinical and experimental immunology, 1994, Volume: 95, Issue:3 Topics: Antibody Specificity; Antigens, CD; Antimony; Autoantibodies; B-Lymphocytes; CD5 Antigens; Child; Child, Preschool; Female; Humans; Immunity, Innate; Immunoglobulin G; Infant; Leishmaniasis, Visceral; Male; Tetanus Toxoid	1994
Treatment of visceral leishmaniasis in a patient with AIDS with antimony and gamma-interferon: remission and prevention of relapse by maintenance therapy with weekly pentamidine. The Netherlands journal of medicine, 1995, Volume: 47, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Interferon-gamma; Leishmaniasis, Visceral; Male; Pentamidine	1995
Treatment of post-kala-azar dermal leishmaniasis. International journal of dermatology, 1995, Volume: 34, Issue:9 Topics: Antimony; Antiparasitic Agents; Humans; Leishmaniasis, Visceral	1995
Visceral leishmaniasis in the BALB/c mouse: a comparison of the in vivo activity of five non-ionic surfactant vesicle preparations of sodium stibogluconate. Journal of drug targeting, 1995, Volume: 3, Issue:1 Topics: Animals; Antimony; Antimony Sodium Gluconate; Bone Marrow; Drug Carriers; Female; Leishmaniasis, Visceral; Liver; Male; Mice; Mice, Inbred BALB C; Microspheres; Particle Size; Spleen; Surface-Active Agents	1995
Amphotericin B for visceral leishmaniasis resistant to pentavalent antimonial drugs in AIDS. The Annals of pharmacotherapy, 1994, Volume: 28, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Substance Abuse, Intravenous	1994
Visceral leishmaniasis and disseminated intravascular coagulation in a dog. Journal of the American Veterinary Medical Association, 1994, Apr-01, Volume: 204, Issue:7 Topics: Animals; Antimony; Antiprotozoal Agents; Disseminated Intravascular Coagulation; Dog Diseases; Dogs; Female; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1994
[Childhood visceral leishmaniasis in the Alpes-Maritimes from 1985 to 1992]. Bulletin de la Societe de pathologie exotique (1990), 1994, Volume: 87, Issue:2 Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; France; Humans; Infant; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies	1994
[Neurological toxicity from pentavalent antimonials during the treatment of visceral leishmaniasis]. Medicina clinica, 1994, Feb-26, Volume: 102, Issue:7 Topics: Adult; Antimony; Antiprotozoal Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Leishmaniasis, Visceral; Male; Muscle Hypertonia; Tremor	1994
[Visceral leishmaniasis: a possible diagnosis in Belgium]. Tijdschrift voor kindergeneeskunde, 1993, Volume: 61, Issue:5 Topics: Antimony; Antiprotozoal Agents; Diagnosis, Differential; Female; Humans; Infant; Leishmaniasis, Visceral; Leukemia; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1993
Acute phase proteins and plasma lipoproteins during antimony treatment in infantile visceral leishmaniasis. Clinical physiology and biochemistry, 1993, Volume: 10, Issue:1 Topics: Antimony; Antiprotozoal Agents; Apolipoproteins; C-Reactive Protein; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1993
Immunochemotherapy of visceral leishmaniasis: a pilot trial of sequential treatment with recombinant interferon-gamma and pentavalent antimony. Journal of interferon research, 1993, Volume: 13, Issue:1 Topics: Adolescent; Adult; Antimony; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Interferon-gamma; Leishmaniasis, Visceral; Male; Pilot Projects; Recombinant Proteins	1993
[Severe forms of visceral infantile leishmaniasis: early salvage treatment by antimonies]. Archives francaises de pediatrie, 1993, Volume: 50, Issue:1 Topics: Antimony; Female; Humans; Infant; Leishmaniasis, Visceral; Male	1993
Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 16, Issue:5 Topics: Acute Disease; Adult; Antimony; Antiprotozoal Agents; Female; Ghana; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis	1993
Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis. Clinical and experimental immunology, 1995, Volume: 102, Issue:3 Topics: Antimony; Biopterins; CD4 Antigens; CD8 Antigens; Humans; Intercellular Adhesion Molecule-1; Leishmaniasis, Visceral; Neopterin; Receptors, Interleukin-2	1995
Multiple host defense defects in failure of C57BL/6 ep/ep (pale ear) mice to resolve visceral Leishmania donovani infection. Infection and immunity, 1996, Volume: 64, Issue:1 Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Causality; Cytokines; Immunity, Innate; Interferon-gamma; Interleukin-4; Leishmania donovani; Leishmaniasis, Visceral; Liver; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; T-Lymphocytes; Th2 Cells	1996
Treatment of kala azar. Lancet (London, England), 1996, Jun-15, Volume: 347, Issue:9016 Topics: Antimony; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine	1996
Visceral leishmaniasis and renal tuberculosis in a patient on maintenance haemodialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:4 Topics: Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Antitubercular Agents; Humans; Kidney Failure, Chronic; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Remission Induction; Renal Dialysis; Tuberculosis, Renal	1996
Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs. The Veterinary record, 1996, Feb-24, Volume: 138, Issue:8 Topics: Animals; Antimony; Antiprotozoal Agents; Biological Availability; Dog Diseases; Dogs; Half-Life; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1996
Meglumine antimoniate-induced pancreatitis. The American journal of gastroenterology, 1996, Volume: 91, Issue:4 Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis	1996
Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5 Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Carriers; Female; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds	1996
Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:3 Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; Atovaquone; Drug Combinations; Female; Leishmania donovani; Leishmaniasis, Visceral; Liver; Mice; Mice, Inbred BALB C; Naphthoquinones; Rats	1996
Antimony/interferon-gamma combination in the treatment of visceral leishmaniasis in AIDS. AIDS (London, England), 1996, Volume: 10, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antimony; CD4-CD8 Ratio; Humans; Interferon-gamma; Leishmaniasis, Visceral; Male; Meglumine; Recurrence	1996
Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis. The American journal of tropical medicine and hygiene, 1996, Volume: 55, Issue:4 Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Disease Models, Animal; Drug Carriers; Injections, Intraperitoneal; Leishmania donovani; Leishmaniasis, Visceral; Liver; Mannans; Mice; Mice, Inbred BALB C	1996
[Infantile visceral leishmaniasis: difficult diagnosis in cases complicated by hemophagocytosis]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1996, Volume: 3, Issue:9 Topics: Antimony; Antiprotozoal Agents; Child, Preschool; Diagnosis, Differential; Histiocytosis, Non-Langerhans-Cell; Humans; Leishmaniasis, Visceral; Male	1996
In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:4 Topics: Animals; Antimony; Antiprotozoal Agents; Cells, Cultured; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Polymerase Chain Reaction	1997
Action of pentamidine-bound nanoparticles against Leishmania on an in vivo model. Parasite (Paris, France), 1994, Volume: 1, Issue:4 Topics: Animals; Antimony; Antiprotozoal Agents; Colloids; Disease Models, Animal; Drug Carriers; Female; Leishmania major; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microspheres; Organometallic Compounds; Pentamidine; Polymethacrylic Acids; Random Allocation	1994
Pentavalent antimonial-induced torsade de pointes. Journal of electrocardiology, 1997, Volume: 30, Issue:2 Topics: Aged; Anti-Arrhythmia Agents; Antimony; Antiprotozoal Agents; Electrocardiography; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Torsades de Pointes	1997
Visceral leishmaniasis in patients infected with the human immunodeficiency virus. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997, Volume: 16, Issue:12 Topics: AIDS-Related Opportunistic Infections; Allopurinol; Amebicides; Amphotericin B; Analysis of Variance; Anti-HIV Agents; Antimetabolites; Antimony; Antiprotozoal Agents; Blood; Bone Marrow; CD4-Positive T-Lymphocytes; Cerebrospinal Fluid; Didanosine; Digestive System; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatic Encephalopathy; HIV; Humans; Intestinal Mucosa; Leishmaniasis, Visceral; Lymphocyte Count; Male; Myocarditis; Neutrophils; Pancreatitis; Pentamidine; Renal Insufficiency; Spain; Zidovudine	1997
Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis. Annals of the New York Academy of Sciences, 1998, Jun-29, Volume: 849 Topics: Allopurinol; Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Follow-Up Studies; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Serum Albumin; Serum Globulins; Time Factors	1998
A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate. The American journal of tropical medicine and hygiene, 1998, Volume: 59, Issue:1 Topics: Adult; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Electrocardiography; Fatal Outcome; Female; Heart; Heart Diseases; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Osmolar Concentration	1998
Visceral leishmaniasis: a lingual presentation in a patient with HIV infection. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1998, Volume: 86, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antimony; Antiprotozoal Agents; Didanosine; HIV Infections; Humans; Laryngitis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain; Tongue Diseases; Zidovudine	1998
Pediatric visceral leishmaniasis in southern France. The Pediatric infectious disease journal, 1998, Volume: 17, Issue:8 Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; France; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Quaternary Ammonium Compounds; Retrospective Studies; Treatment Failure; Treatment Outcome	1998
Clarification of comments on trial of aminosidine in visceral leishmaniasis. BMJ (Clinical research ed.), 1998, Oct-31, Volume: 317, Issue:7167 Topics: Anti-Bacterial Agents; Antimony; Drug Costs; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Paromomycin	1998
Visceral leishmaniasis in District Dir, NWFP. JPMA. The Journal of the Pakistan Medical Association, 1998, Volume: 48, Issue:6 Topics: Abdomen; Anemia; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; Fever; Hepatomegaly; Humans; Hypergammaglobulinemia; Leishmania donovani; Leishmaniasis, Visceral; Leukopenia; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pakistan; Splenomegaly; Thrombocytopenia; Weight Loss	1998
Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:2 Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Arsenites; Drug Resistance, Multiple; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1999
[Chronic visceral leishmaniasis during chemotherapy for metastatic osteosarcoma]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1998, Volume: 5, Issue:3 Topics: Amphotericin B; Antifungal Agents; Antimony; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Child; Chronic Disease; Humans; Interferon-gamma; Leishmaniasis, Visceral; Liposomes; Lung Neoplasms; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Osteosarcoma; Recurrence; Spinal Neoplasms	1998
Disposition of antimony and aminosidine combination after multiple subcutaneous injections in dogs. Veterinary journal (London, England : 1997), 1999, Volume: 157, Issue:3 Topics: Amebicides; Animals; Antimony; Antiprotozoal Agents; Area Under Curve; Chromatography, Liquid; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluorometry; Half-Life; Injections, Subcutaneous; Least-Squares Analysis; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Spectrophotometry, Atomic	1999
Revival of tetracyclines--in the treatment of visceral leishmaniasis? Schweizerische medizinische Wochenschrift, 1999, May-29, Volume: 129, Issue:21 Topics: Adult; Antimony; Doxycycline; Humans; Leishmaniasis, Visceral; Male; Opportunistic Infections; Recurrence; Tetracyclines; Treatment Outcome	1999
HIV viral load and response to antileishmanial chemotherapy in co-infected patients. AIDS (London, England), 1999, Oct-01, Volume: 13, Issue:14 Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antimony; Antiprotozoal Agents; Female; HIV-1; Humans; Leishmania donovani; Leishmaniasis, Visceral; Male; Middle Aged; Treatment Outcome; Viral Load	1999
Short report: improved diagnosis and follow-up of canine leishmaniasis using amastigote-based indirect immunofluorescence. The American journal of tropical medicine and hygiene, 1999, Volume: 61, Issue:4 Topics: Allopurinol; Animals; Antibodies, Protozoan; Antimetabolites; Antimony; Dog Diseases; Dogs; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Leishmania infantum; Leishmaniasis, Visceral	1999
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients. The American journal of tropical medicine and hygiene, 1999, Volume: 61, Issue:5 Topics: Adult; Amylases; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Creatinine; Female; HIV Infections; HIV-1; Humans; Leishmania infantum; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Recurrence; Retrospective Studies; Vomiting	1999
Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis. Infection and immunity, 2000, Volume: 68, Issue:1 Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Disease Models, Animal; Enzyme Inhibitors; Female; Granulomatous Disease, Chronic; Guanidines; Interferon-gamma; Leishmaniasis, Visceral; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase; Nitric Oxide Synthase Type II	2000
Combined liposomal immuno- and chemotherapy of visceral leishmaniasis. Arzneimittel-Forschung, 1999, Volume: 49, Issue:11 Topics: Animals; Antimony; Antiprotozoal Agents; Bone Marrow Cells; Drug Carriers; Drug Combinations; Female; Immunotherapy; Interferon-gamma; Kupffer Cells; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Liver; Macrophages; Mice; Mice, Inbred Strains; Recombinant Proteins; Spleen; Tissue Distribution	1999
[Nephrotic syndrome and acute pancreatitis related to glucantime administration]. Anales de medicina interna (Madrid, Spain : 1984), 2000, Volume: 17, Issue:1 Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Nephrotic Syndrome; Organometallic Compounds; Pancreatitis	2000
Antimony excretion in a patient with renal impairment during meglumine antimoniate therapy. Pharmacotherapy, 2000, Volume: 20, Issue:9 Topics: Antimony; Antiprotozoal Agents; Creatinine; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Oliguria; Organometallic Compounds; Renal Insufficiency; Shock, Septic	2000
Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials. Transplantation, 2000, Sep-15, Volume: 70, Issue:5 Topics: Antimony; Antiprotozoal Agents; Humans; Kidney Transplantation; Leishmaniasis, Visceral; Male; Middle Aged; Organometallic Compounds	2000
Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis. The Journal of infectious diseases, 2000, Volume: 182, Issue:5 Topics: Animals; Antimony; Interferon-gamma; Interleukin-12; Interleukin-4; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Mice, Knockout	2000
Mononuclear cell recruitment, granuloma assembly, and response to treatment in experimental visceral leishmaniasis: intracellular adhesion molecule 1-dependent and -independent regulation. Infection and immunity, 2000, Volume: 68, Issue:11 Topics: Animals; Antimony; Cell Movement; Granuloma; Intercellular Adhesion Molecule-1; Interferon-gamma; Leishmaniasis, Visceral; Leukocytes, Mononuclear; Mice; Mice, Inbred C57BL; Monocytes; T-Lymphocytes	2000
Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas. Acta tropica, 2001, Dec-21, Volume: 80, Issue:3 Topics: Animals; Antimony; Antiprotozoal Agents; Cell Line; Drug Resistance; Endemic Diseases; Humans; Leishmania infantum; Leishmaniasis, Visceral; Life Cycle Stages; Parasitic Sensitivity Tests; Phenotype	2001
Drug resistance in Indian visceral leishmaniasis. Tropical medicine & international health : TM & IH, 2001, Volume: 6, Issue:11 Topics: Aminoquinolines; Amphotericin B; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Resistance; Geography; History, 20th Century; History, 21st Century; Humans; India; Leishmaniasis, Visceral; Paromomycin; Pentamidine; Phosphorylcholine; Treatment Outcome	2001
The irreplaceable image: Acute toxicity in erythroid bone marrow progenitors after antimonial therapy. Haematologica, 2001, Volume: 86, Issue:12 Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Bone Marrow Cells; Erythroid Precursor Cells; Humans; Leishmaniasis, Visceral; Male	2001
[Visceral leishmaniasis associated with human immunodeficiency virus infection (reply)]. Enfermedades infecciosas y microbiologia clinica, 2002, Volume: 20, Issue:3 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Administration Schedule; HIV Infections; Humans; Immunocompromised Host; Leishmaniasis, Visceral; Prospective Studies; Recurrence; Spain; Viral Load	2002
Antileishmanial activity of antimonials entrapped in liposomes. Nature, 1978, Mar-02, Volume: 272, Issue:5648 Topics: Animals; Antimony; Antimony Potassium Tartrate; Antimony Sodium Gluconate; Dose-Response Relationship, Drug; Gluconates; Leishmaniasis, Visceral; Liposomes; Mice	1978
Action of p-(4-amidino-phenoxy)-benzaldehyde-p-amidino-phenylhydrazone dihydrochloride on Leishmania donovani infections in the golden hamster. Annals of tropical medicine and parasitology, 1978, Volume: 72, Issue:6 Topics: Amidines; Animals; Antimony; Antimony Sodium Gluconate; Cricetinae; Drug Evaluation, Preclinical; Leishmaniasis, Visceral; Liver; Meglumine; Mesocricetus; Pentamidine	1978
[Visceral kala-azar disease in a child (author's transl)]. Deutsche medizinische Wochenschrift (1946), 1978, Mar-10, Volume: 103, Issue:10 Topics: Alanine Transaminase; Animals; Antimony; Arthritis, Juvenile; Aspartate Aminotransferases; Brucellosis, Bovine; Cattle; Child; Diagnosis, Differential; Hepatomegaly; Humans; Leishmaniasis, Visceral; Leukemia; Male; Typhoid Fever	1978
Testing of drugs for antileishmanial activity in golden hamsters infected with Leishmania donovani. International journal for parasitology, 1977, Volume: 7, Issue:6 Topics: Amidines; Aminoquinolines; Animals; Antimalarials; Antimony; Antiprotozoal Agents; Cricetinae; Drug Evaluation, Preclinical; Leishmaniasis, Visceral; Male; Meglumine; Mesocricetus	1977
Study of the outbreak of kala-azar epidemic in Bihar. The Journal of the Association of Physicians of India, 1978, Volume: 26, Issue:6 Topics: Adolescent; Adult; Antimony; Child; Child, Preschool; Disease Outbreaks; Female; Humans; India; Infant; Infant, Newborn; Leishmaniasis, Visceral; Male; Middle Aged; Pentamidine	1978
[Visceral leishmaniasis in 2 siblings and their father]. Pediatrie, 1978, Volume: 33, Issue:8 Topics: Adult; Antimony; Child; Female; France; Humans; Leishmaniasis, Visceral; Male; Meglumine; Pentamidine	1978
Current concepts in parasitology. Leishmaniasis. The New England journal of medicine, 1979, Feb-15, Volume: 300, Issue:7 Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral	1979
[Kala-azar following vacation at the Mediterranean]. Die Medizinische Welt, 1976, Jul-23, Volume: 27, Issue:30 Topics: Adult; Antimony; Bone Marrow; Bone Marrow Cells; Humans; Leishmaniasis, Visceral; Male; Mediterranean Islands; Spain	1976
["Imported" visceral leishmaniasis (case report and several aspects of the problem)]. Terapevticheskii arkhiv, 1976, Volume: 48, Issue:12 Topics: Adult; Amino Sugars; Antimony; Antiprotozoal Agents; Diagnosis, Differential; Humans; Leishmaniasis, Visceral; Male; Time Factors; USSR	1976
Leishmania donovani: therapeutic and prophylaciic action of antimony dextran glycoside (RL-712) in the golden hamster. Experimental parasitology, 1975, Volume: 37, Issue:3 Topics: Animals; Antimony; Cricetinae; Dextrans; Glycosides; Heart; Injections; Injections, Intraperitoneal; Injections, Subcutaneous; Leishmania; Leishmaniasis, Visceral; Liver; Male; Spleen	1975
Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1975, Volume: 69, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Antibodies; Antimony; Child; Child, Preschool; Female; Humans; Infant; Intradermal Tests; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Male; Mediterranean Islands; Middle Aged; Remission, Spontaneous	1975
Rapidly reversible depression of delayed hypersensitivity in two children with visceral leishmaniasis. Infection, 1975, Volume: 3, Issue:4 Topics: Amino Sugars; Antimony; Child, Preschool; Female; Humans; Hypersensitivity, Delayed; Immunosuppression Therapy; Leishmaniasis, Visceral; Lymphocyte Activation; Male; Skin Tests	1975
Return of kala-azar. Journal of the Indian Medical Association, 1975, Aug-01, Volume: 65, Issue:3 Topics: Animals; Antimony; Humans; India; Insect Control; Leishmaniasis, Visceral; Psychodidae	1975
Visceral leishmaniasis in the BALB/c mouse: antimony tissue disposition and parasite suppression after the administration of free stibogluconate. Annals of tropical medicine and parasitology, 1992, Volume: 86, Issue:1 Topics: Acute Disease; Animals; Antimony; Antimony Sodium Gluconate; Chronic Disease; Female; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C	1992
[Visceral leishmaniasis in HIV infection. A totally opportunistic infection]. Presse medicale (Paris, France : 1983), 1992, Oct-24, Volume: 21, Issue:35 Topics: Adult; AIDS-Related Opportunistic Infections; Antimony; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Retrospective Studies	1992
[Visceral leishmaniasis and AIDS. Apropos of 2 cases with different clinical course patterns]. Revista clinica espanola, 1992, Volume: 190, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Antimony; Bone Marrow Examination; Female; Fever of Unknown Origin; Humans; Leishmaniasis, Visceral; Male	1992
[Visceral leishmaniasis: a study of 15 cases]. Anales de medicina interna (Madrid, Spain : 1984), 1992, Volume: 9, Issue:4 Topics: Age Factors; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Serologic Tests; Sex Factors; Spain	1992
Ketoconazole in the treatment of antimony- and pentamidine-resistant kala-azar. The Journal of infectious diseases, 1992, Volume: 166, Issue:1 Topics: Antimony; Drug Resistance; Humans; Ketoconazole; Leishmaniasis, Visceral; Pentamidine	1992
[Transitory acute kidney insufficiency and insulin-dependent after treatment of kala-azar with pentamidine and N-methylglucamine antimony]. Archives francaises de pediatrie, 1991, Volume: 48, Issue:5 Topics: Acute Kidney Injury; Antimony; Antiprotozoal Agents; Child, Preschool; Diabetes Mellitus, Type 1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Nephrotic Syndrome; Pentamidine	1991
Response to chemotherapy in experimental visceral leishmaniasis: T cell-dependent but interferon-gamma- and interleukin-2-independent. The Journal of infectious diseases, 1991, Volume: 163, Issue:3 Topics: Animals; Antibodies, Monoclonal; Antimony; Disease Models, Animal; Female; Interferon-gamma; Interleukin-2; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; T-Lymphocytes	1991
Tumor necrosis factor (cachectin) in human visceral leishmaniasis. The Journal of infectious diseases, 1991, Volume: 163, Issue:4 Topics: Acute Disease; Antimony; Antiprotozoal Agents; Cells, Cultured; Combined Modality Therapy; Female; Humans; Interferon-gamma; Leishmaniasis, Visceral; Macrophages; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recombinant Proteins; Tumor Necrosis Factor-alpha	1991
Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. The New England journal of medicine, 1990, Jan-04, Volume: 322, Issue:1 Topics: Adolescent; Adult; Antimony; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Interferon-gamma; Leishmaniasis, Visceral; Male; Recombinant Proteins	1990
Immunotherapy for parasitic disease. The New England journal of medicine, 1990, Jan-04, Volume: 322, Issue:1 Topics: Antimony; Drug Therapy, Combination; Humans; Interferon-gamma; Leishmaniasis, Visceral; Recombinant Proteins	1990
Suppression of both antimony-susceptible and antimony-resistant Leishmania donovani by a bis(benzyl)polyamine analog. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:5 Topics: Animals; Antimalarials; Antimony; Bone Marrow; Cricetinae; Dogs; Drug Resistance; Leishmania donovani; Leishmaniasis, Visceral; Liver; Macrophages; Mesocricetus; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Polyamines	1990
Urea stibamine: an improved method of preparation and its antileishmanial activity. Biochemical medicine and metabolic biology, 1987, Volume: 38, Issue:1 Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; DNA Replication; Glycolysis; Indicators and Reagents; Leishmania donovani; Leishmaniasis, Visceral; Mesocricetus; Organometallic Compounds; Protein Biosynthesis; RNA; Urea	1987
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. The Journal of clinical investigation, 1989, Volume: 83, Issue:3 Topics: Adolescent; Adult; Aged; Animals; Antigens, Protozoan; Antimony; Cells, Cultured; Child; Dose-Response Relationship, Immunologic; Female; Humans; Immune Tolerance; Immunity, Cellular; Indomethacin; Infant; Leishmania donovani; Leishmaniasis, Visceral; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Receptors, Fc; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory	1989
[Kala-azar. Apropos of a case report in a Belgian woman]. Acta clinica Belgica, 1989, Volume: 44, Issue:5 Topics: Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sorbitol	1989
Chemotherapy of antimonial compounds in kala-azar infection. Part IV. Further observations on the therapeutic values of urea stibamine. By U.N. Brahmachari, 1922. The Indian journal of medical research, 1989, Volume: 89 Topics: Antimony; Antiprotozoal Agents; History, 20th Century; Humans; Leishmaniasis, Visceral; Organometallic Compounds; Urea	1989
Chemotherapy of antimonial compounds in kala-azar infection. Part I. By U. N. Brahmachari, 1922. The Indian journal of medical research, 1989, Volume: 89 Topics: Animals; Antimony; History, 20th Century; Humans; Leishmaniasis, Visceral	1989
Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1988, Volume: 82, Issue:1 Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Gluconates; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol	1988
Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate. The Journal of pharmacy and pharmacology, 1986, Volume: 38, Issue:7 Topics: Animals; Antimony; Antimony Sodium Gluconate; Gluconates; Kinetics; Leishmania donovani; Leishmaniasis, Visceral; Liver; Male; Mice; Mice, Inbred BALB C; Micelles; Pharmaceutical Vehicles; Surface-Active Agents; Tissue Distribution	1986
Biodegradable microspheres: polyacryl starch microparticles as a delivery system for the antileishmanial drug, sodium stibogluconate. The Journal of pharmacy and pharmacology, 1987, Volume: 39, Issue:10 Topics: Animals; Antimony; Antimony Sodium Gluconate; Biotransformation; Cricetinae; Excipients; Female; Gluconates; Leishmania donovani; Leishmaniasis, Visceral; Liver; Mesocricetus; Mice; Mice, Inbred BALB C; Microspheres; Spectrophotometry, Atomic; Starch	1987
Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. The Journal of pharmacy and pharmacology, 1988, Volume: 40, Issue:3 Topics: Animals; Antimony; Antimony Sodium Gluconate; Chemistry, Pharmaceutical; Female; Gluconates; Leishmaniasis, Visceral; Liposomes; Liver; Mice; Mice, Inbred BALB C; Spectrophotometry, Atomic	1988
Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells. Infection and immunity, 1985, Volume: 50, Issue:1 Topics: Animals; Antigens, Protozoan; Antimony; Immune Tolerance; Interleukin-2; Leishmania donovani; Leishmaniasis, Visceral; Lymphocyte Activation; Macrophage Activation; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred Strains; Organometallic Compounds; Spleen; T-Lymphocytes, Regulatory	1985
[Kala-azar in pregnant women]. Presse medicale (Paris, France : 1983), 1986, May-17, Volume: 15, Issue:20 Topics: Adult; Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pregnancy; Pregnancy Complications, Infectious	1986
[Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases]. Pathologie-biologie, 1985, Volume: 33, Issue:5 Pt 2 Topics: Adolescent; Adult; Antimony; Antimony Sodium Gluconate; Child; Child, Preschool; Female; Gluconates; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Splenectomy	1985
[Treatment of visceral leishmaniasis]. Archives francaises de pediatrie, 1985, Volume: 42 Suppl 2 Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance, Microbial; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Pentamidine	1985
The use of recombinant gamma interferon associated with pentavalent antimony in therapy for visceral leishmaniasis. Memorias do Instituto Oswaldo Cruz, 1988, Volume: 83 Suppl 1 Topics: Antimony; Humans; Interferon-gamma; Leishmaniasis, Visceral; Recombinant Proteins	1988
Severe leucopenia during treatment of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1988, Volume: 82, Issue:3 Topics: Antimony; Antiprotozoal Agents; Child; Child, Preschool; Humans; Infant; Leishmaniasis, Visceral; Leukocyte Count; Leukopenia; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol	1988
Glucantime-resistant visceral leishmaniasis in immunocompromised patients. The American journal of medicine, 1988, Volume: 85, Issue:1 Topics: Antimony; Antiprotozoal Agents; Humans; Immune Tolerance; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol	1988
[Visceral leishmaniasis mimicking histiocytic marrow reticulosis]. Sangre, 1986, Volume: 31, Issue:1 Topics: Adult; Antimony; Bone Marrow; Diagnosis, Differential; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Lymphatic Diseases; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phagocytosis	1986
[Agranulocytosis caused by glucantime in the treatment of kala-azar]. Medicina clinica, 1986, Mar-15, Volume: 86, Issue:10 Topics: Agranulocytosis; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1986
Humoral factors during South American visceral leishmaniasis. Annals of tropical medicine and parasitology, 1986, Volume: 80, Issue:4 Topics: Adolescent; Adult; Antibodies; Antigen-Antibody Complex; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Complement Fixation Tests; Female; Humans; Infant; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rheumatoid Factor	1986
[Value of the ELISA IgG and IgM test in the diagnosis and post-therapeutic monitoring of kala-azar]. Annales de la Societe belge de medecine tropicale, 1985, Volume: 65, Issue:1 Topics: Antimony; Antiprotozoal Agents; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Immunoglobulin G; Immunoglobulin M; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rheumatoid Factor	1985
Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. The Journal of clinical investigation, 1985, Volume: 76, Issue:6 Topics: Antigens, Differentiation, T-Lymphocyte; Antigens, Protozoan; Antigens, Surface; Antimony; Humans; Interferon-gamma; Interleukin-2; Leishmania donovani; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Lymphocyte Activation; Lymphocytes	1985
Enhancement of Glucantime therapy of murine Leishmania donovani infection by a synthetic immunopotentiating compound (CP-46,665-1). The American journal of tropical medicine and hygiene, 1985, Volume: 34, Issue:2 Topics: Adjuvants, Immunologic; Animals; Antimony; Antiprotozoal Agents; Drug Therapy, Combination; Female; Leishmania; Leishmaniasis, Visceral; Lymphokines; Macrophage Activation; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Organometallic Compounds; Piperidines; Thioglycolates	1985
Chemotherapy of visceral leishmaniasis (Leishmania donovani) in the squirrel monkey (Saimiri sciureus). Annals of tropical medicine and parasitology, 1985, Volume: 79, Issue:1 Topics: Animals; Antimony; Antiprotozoal Agents; Female; Leishmania; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Saimiri	1985
Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis. Infection and immunity, 1985, Volume: 48, Issue:2 Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antimony; Antiprotozoal Agents; Combined Modality Therapy; Cricetinae; Female; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mesocricetus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Organometallic Compounds	1985
[Agranulocytosis caused by glucantime (N-methylglucamine antimoniate) during treatment of kala-azar]. Medicina clinica, 1985, May-25, Volume: 84, Issue:20 Topics: Adult; Agranulocytosis; Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1985
Immunosuppression associated with visceral leishmaniasis of hamsters. Parasite immunology, 1985, Volume: 7, Issue:4 Topics: Animals; Antigens, Protozoan; Antimony; Cricetinae; Immune Tolerance; Leishmania; Leishmaniasis, Visceral; Lymphocyte Activation; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Time Factors	1985
[Toxicity of Glucantime. A case]. Annales de medecine interne, 1985, Volume: 136, Issue:4 Topics: Adult; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1985
[Description of a case of visceral leishmaniasis. Epidemiologic, diagnostic and therapeutic considerations]. Minerva pediatrica, 1985, Jun-30, Volume: 37, Issue:11-12 Topics: Antimony; Child, Preschool; Humans; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1985
[Clinical, hematologic, and biochemical study of a case of kala-azar (visceral leishmaniasis) observed in Belgium]. Revue medicale de Liege, 1973, Apr-15, Volume: 28, Issue:8 Topics: Adult; Anemia; Antimony; Belgium; Blood Platelets; Blood Protein Electrophoresis; Bone Marrow Cells; Enzymes; Erythrocyte Count; Eye Manifestations; Humans; Immunoglobulins; Leishmaniasis, Visceral; Leukocyte Count; Lipids; Male; Mesylates; Splenomegaly	1973
A relapse case of post-kala-azar dermal leishmaniasis (P.K.D.L.). Indian journal of dermatology, 1973, Volume: 18, Issue:3 Topics: Antimony; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Recurrence; Skin Diseases, Infectious	1973
Kala-azar. Tropical doctor, 1973, Volume: 3, Issue:3 Topics: Africa; Amphotericin B; Animals; Antimony; Asia, Western; Biopsy, Needle; Bone Marrow Examination; Brazil; Diagnosis, Differential; Disease Reservoirs; Humans; Hypergammaglobulinemia; Immunoglobulin G; India; Leishmaniasis, Visceral; Skin Tests; Splenomegaly; Stilbamidines; Zoonoses	1973
Visceral leishmaniasis in an English girl. Proceedings of the Royal Society of Medicine, 1973, Volume: 66, Issue:11 Topics: Adolescent; Antimony; Antiprotozoal Agents; Asia, Western; Female; Fever; Gluconates; Humans; Leishmaniasis, Visceral; Sri Lanka; Travel	1973
Leishmaniasis in the United States. A report of ten cases in military personnel. JAMA, 1973, Nov-19, Volume: 226, Issue:8 Topics: Adolescent; Adult; Antibodies; Antimony; Humans; Injections, Intramuscular; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Male; Military Medicine; Panama; Recurrence; United States	1973
Red cell survival and iron kinetics in kala-azar. The Journal of tropical medicine and hygiene, 1974, Volume: 77, Issue:5 Topics: Amino Sugars; Anemia; Antimony; Antiprotozoal Agents; Bilirubin; Blood Volume; Child, Preschool; Chromium Radioisotopes; Erythrocyte Aging; Erythrocyte Count; Erythrocytes; Humans; Infant; Iron; Iron Radioisotopes; Kinetics; Leishmaniasis, Visceral; Plasma Volume; Radioisotopes; Sodium Isotopes; Sorbitol; Splenomegaly; Time Factors	1974
[Behavior of antibodies (titrated by means of the immunofluorescence test) in visceral leishmaniasis treated by antimony therapy]. La Pediatria, 1970, Jul-30, Volume: 78, Issue:3 Topics: Antimony; Child, Preschool; Fluorescent Antibody Technique; Humans; Infant; Leishmaniasis, Visceral	1970
[Leishmaniasis]. La Presse medicale, 1969, Jan-22, Volume: 77, Issue:4 Topics: Amidines; Amphotericin B; Anemia; Animals; Antimony; Blood Protein Electrophoresis; Child, Preschool; Chloroquine; Complement Fixation Tests; Diagnosis, Differential; Dogs; Haplorhini; Hepatomegaly; Humans; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Leukopenia; Liver Function Tests; Metronidazole; Rodentia; Skin Tests; Splenomegaly	1969
Kala-azar in childhood: a survey of clinical and laboratory findings and prognosis in 44 childhood cases. Clinical pediatrics, 1972, Volume: 11, Issue:8 Topics: Amidines; Antimony; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Prognosis; Splenectomy; Turkey	1972
Kala-azar imported into the USA. Pediatrics, 1972, Volume: 50, Issue:3 Topics: Animals; Antimony; Bone Marrow; Bone Marrow Cells; Child; Child, Preschool; Cricetinae; Gluconates; Histiocytes; Humans; Leishmania; Leishmaniasis, Visceral; Male; Mexico; Sodium; Spain; Spleen; United States	1972
[Kala-azar in infants]. Journal des sciences medicales de Lille, 1971, Volume: 89, Issue:3 Topics: Antimony; Antiprotozoal Agents; Hepatomegaly; Humans; Infant, Newborn; Infant, Newborn, Diseases; Leishmaniasis, Visceral; Male; Serologic Tests; Splenomegaly	1971
Splenectomy in treatment of drug resistant kala-azar. Journal of the Indian Medical Association, 1971, Dec-16, Volume: 57, Issue:12 Topics: Adolescent; Adult; Antimony; Female; Humans; Leishmaniasis, Visceral; Male; Splenectomy	1971
[Visceral leishmaniasis: ultrastructural findings in the bone marrow cells]. Archivio "de Vecchi" per l'anatomia patologica e la medicina clinica, 1967, Volume: 49, Issue:3 Topics: Antimony; Bone Marrow; Bone Marrow Cells; Cytoplasm; Humans; Leishmania; Leishmaniasis, Visceral; Microscopy, Electron	1967
[Leishmaniasis (kala-azar, oriental sore, South American leishmaniasis)]. Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete, 1967, Volume: 48, Issue:6 Topics: Adult; Animals; Antimony; Child; Diagnosis, Differential; Diptera; Disease Vectors; Dog Diseases; Dogs; Female; Humans; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Male; Tropical Climate	1967
[Visceral leishmaniasis (kala-azar)]. Praxis, 1967, Nov-16, Volume: 56, Issue:46 Topics: Adolescent; Adult; Antimony; Hepatomegaly; Humans; Leishmaniasis, Visceral; Male; Splenomegaly; Switzerland	1967
[Kala-azar in Mediterranean vacationers]. Deutsche medizinische Wochenschrift (1946), 1968, Jul-05, Volume: 93, Issue:27 Topics: Adult; Antimony; Disease Reservoirs; Female; Germany, West; Humans; Leishmaniasis, Visceral; Male; Mediterranean Islands; Recreation; Travel	1968
Visceral leishmaniasis (kala-azar) in children in southern Iran. Annals of tropical medicine and parasitology, 1968, Volume: 62, Issue:2 Topics: Antimony; Biopsy; Bone Marrow Examination; Child; Female; Humans; Iran; Leishmania; Leishmaniasis, Visceral; Liver; Male; Nutrition Disorders; Sex Factors; Spleen	1968
[Kala-azar in the Netherlands]. Nederlands tijdschrift voor geneeskunde, 1969, Aug-16, Volume: 113, Issue:33 Topics: Adolescent; Antimony; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Male; Netherlands	1969